PROFESSIONAL EXPERIENCE - Interspondinterspond.com/wp-content/uploads/2016/12/... · Macchi Z1,...

mailto:[email protected]

06/08/2017 2

PROFESSIONAL EXPERIENCE

1992 - Present Neurologist/ President, Wesley Neurology Clinic, Cordova, TN

1982 – Present Consultant Neurologist, St. Francis Hospital, Memphis, TN

1982 – Present Neurologist, Methodist Hospitals of Memphis, Memphis, TN

1978 – Present Consultant Neurologist, Baptist Memorial Hospital, Memphis,

TN

1978 – Present Consultant Neurologist, MDA Neuromuscular Clinic, Memphis,

TN

1978 – Present Consultant Neurologist, St. Jude Children's Research Hospital,

Memphis, TN

1977 – Present Consultant Neurologist, LeBonheur Children's Medical Center,

Memphis, TN

1977 – Present Neurologist, The Regional Medical Center (The MED),

Memphis, TN

1977 – Present Consultant Neurologist, Veterans Association Medical Center

(VAMC), Memphis, TN

1986 – 1992 Neurologist/ Vice President, The Neurosurgical Group of

Memphis, Memphis, TN

1976 – 1986 Neurologist, University Physicians Foundation/ University of

Tennessee Medical Group, Memphis, TN

PROFESSIONAL MEMBERSHIPS

2014 – Present NEALS Research Group

2014 – Present San Fernando Medical School, Chapter Peruvian American Medical Society

(PAMS)

2014 – Present Solane (Latino American Society of Neuromuscular Diseases)

2014 – Present Tennessee Medical Association, Delegate

2013 – Present American Neurological Association, Tennessee Liaison

2013 – Present PAMS, Member at Large

2012 – Present ALS Integrated Service

2011 – Present Midwest ALS Society

2010 – Present Corporate International Neuromuscular Research Group (CINRG)

2010 – Present PAMS, Southeast Chapter, Secretary

2006 – Present Clinica Esperanza (Indigent Clinic), Attending

2003 – Present Memphis Academy of Neurology, President

2002 – Present Church Health Clinic, Consultant

06/08/2017 3

1997 – Present St. Joseph Hospital, Peru, International Coordinator of Advisory Board

1989 – Present American Association for Electrodiagnostic Medicine, State of Tennessee

Liaison

1985 – Present Multiple Sclerosis Society, Professional Advisory Board

1984 - Present Memphis Neurosciences Center, Methodist Hospitals of Memphis

1982 – Present Memphis Muscular Dystrophy Association, Medical Advisory Board

1980 – Present Memphis Epilepsy Foundation, Professional Advisory Board

2012 – 2014 San Fernando University Chapter, President

2011 ALS RG

2001 – 2002 Tennessee Academy of Neurology, Secretary-Treasurer

2000 – 2005 World Federation of Neurology, ALS Section

1997 – 2002 Memphis Academy of Neurology, Secretary-Treasurer

1984 Memphis Academy of Neurology, President

1982 American Academy of Neurology, Fellow

American Association for the Advancement of Science

American Clinical Neurophysiology Society

American College of Physicians, Fellow

American Electroencephalographic Society

American Federation for Clinical Research

American Neurological Association, Fellow

American Society of Neurorehabilitation, Contributor, Certification Examination

Central Society for Clinical Research

Clinica Chincha

InterAmerican College of Physicians and Surgeons

International Society for Evoked Responses

The Society for Neuroscience, Memphis Chapter

Parkinson's Disease Association, Memphis Chapter, Advisory Board, Director

Peruvian Society of Electroencephalography and Clinical Neurophysiology

Society of Latin American Physicians

Southern EEG Society

The Wernikes Medical Society

UTHSC Department of Neurology

World Muscle Society

PROFESSIONAL COMMITTEES

2014 – Present Muscle Study Group

2014 – Present PAMS, Membership Committee, Chair/ President

2013 – Present PAMS, Executive Committee

2011 – Present PAMS, Clinical Committee

2011 – Present PAMS, Education Committee

2011 – Present PAMS, Membership Committee

2002 – Present UT Neurology Department, Reviewer Member, Promotion Committee

2001 – Present World Federation of Neurology, Publication Committee

1997 – Present American Association of Electrodiagnostic Medicine, Education Committee

1996 – Present Memphis and Shelby County Medical Society, Ethics Committee

1993 – Present American Association of Electrodiagnostic Medicine, Examiner

1993 – Present Methodist Hospitals of Memphis, Education Committee

1985 – Present Board of Psychiatry & Neurology, Examiner

1983 – Present Regional Medical Center, Special Care Units Committee

06/08/2017 4

1981 – Present University of Tennessee Hospital, Special Units Committee

2000 – 2001 Shelby County Medical Society, Ethics Committee

1999 Methodist Hospital, Ethics in Research Committee

1993 – 1995 American Association of Electrodiagnostic Medicine, Workshop Committee

1990-1995 William F. Bowld/ University of Tennessee Hospital, Liaison Committee for

Supportive Services Laboratories

Methodist Hospitals of Memphis, Intensive Care Units Committee

UTHSC Department of Neurology, Promotions Committee

EDITORIAL APPOINTMENTS

2011 – Present Neurology, Reviewer

2010 – Present Journal of Neurology, Neurosurgery and Psychiatry, Reviewer

2006 – Present Southern Medical Journal, Reviewer

2005 – Present Journal of Neurology, Reviewer

2004 – Present European Neurology, Reviewer

2000 – Present Journal of Clinical Neuromuscular Disease, Reviewer

1998 – Present Journal of Clinical Neuromuscular Disease, Editorial Board

1992 – Present Chest, Reviewer

1992 – Present Muscle & Nerve, Reviewer

1986 – Present Alabama Medical Journal, Reviewer

1986 – Present FDA-Orphan Products, Reviewer, Grant

1986 – Present New England Journal of Medicine, Reviewer

1998 – 1999 MEDICO Interamericano, Guest Editor

1992 United Scleroderma Foundation, Reviewer

Medical Annals of the San Marcos Medical School, Editorial Board, Consulting

Member

AWARDS AND RECOGNITION

2014 Fellow American Neurological Association

2013 Regional Government of Huanuco Peru. Distinguished Visitor

2008 – 2010 Best Doctors in America by Best Doctors, Inc.

2001, 2002, 2003,

2005, 2006, 2009, 2010 Best Doctors in Memphis by Memphis Magazine

2008 – 2009 American Academy of Family Physicians, Active Teacher in Family Medicine

2007 Life Achievement Award, Memphis by Methodist University

1994, 2000,

2006, 2007 Golden Apple Award - Class of 1994, University of Tennessee, Memphis, College

of Medicine - Neurology Clerkship

2001 Colonel, Aide de Camp, Governor’s Staff of The Honorable Don Sunquist,

1994 Good Samaritan Award, Church Health Center and the Memphis Health Care News

1994 Most Outstanding Indigent Service in the City of Memphis, Shelby County Medical

Society

1993 Outstanding Hispanic of the Year in the Field of Medicine

1992 Golden Apple Award - Class of 1993, University of Tennessee, Memphis, College

of Medicine - Neurosciences Course

06/08/2017 5

1991 Award of Merit, City of Memphis

1968 President, Peruvian Association of Students in Neuropsychiatry

1961 Editor, St. Paul School Yearbook

TEACHING ACTIVITES

2002 – Present Honorary Professor, Universidad Ricardo Palma, Lima, Peru

2000 – Present Associate Professor, Department of Pathology, University of Memphis,

Memphis, TN

1999 – Present Director, Electromyography Laboratory Methodist Hospitals of Memphis,

Memphis, TN

1997 – Present Professor, Department of Neurology, University of Tennessee Health Science

Center (UTHSC), Memphis, TN

1997 – Present Professor, Department of Neurology, University of Tennessee, Memphis, TN

1992 – Present Co-Director, University of Tennessee, Memphis Neurology Residency Program,

Memphis, TN

1992 – Present Consultant, Electromyography Laboratory, University of Tennessee Hospital,

Memphis, TN

1980 – Present Consultant, Rehab Engineering, Memphis, TN

1979 – Present Director, University of Tennessee, Memphis Clinical Neurophysiology

Fellowship, Memphis, TN

1978 – Present Director, Medical Advisory Board, Memphis Regional Muscular Dystrophy

Association, Memphis, TN

1977 – Present Director, Muscular Dystrophy Association Clinic, Memphis, TN

2012 – 2014 Acting Chairman, Department of Neurology, UTHSC, Memphis, TN

2004 – 2015 Chief of Neurology, Methodist Hospitals of Memphis, Memphis, TN

1993 & 2012 American Association for Electrodiagnostic Medicine, Videotape for teaching

1990 – 2015 Director of Neurology, Methodist Hospitals of Memphis, Memphis, TN

1985 – 1992 Director, University of Tennessee, Memphis Neurology Residency Program,

Memphis, TN

1978 – 1997 Associate Professor, Department of Pathology, University of Tennessee,

Memphis, TN

1977 – 1997 Associate Professor, Department of Neurology, University of Tennessee,

Memphis, TN

1977 – 1992 Director, Electromyography and Electrodiagnostic Laboratory, Regional Medical

Center and University of Tennessee Hospital, Memphis, TN

1975 – 1977 Visiting Associate, Medical Neurology Branch, NIH, Bethesda, MD

1970 – 1971 Instructor, Neuroanatomy, San Marcos University, Lima, Peru

Muscle and Nerve Histopathology, Videotape for teaching

RESEARCH ACTIVITIES

CINRG. Fibroblasts Muscular Dystrophy. 2014 – Present

CIRNG. Natural History of Beckers Muscular Dystrophy. 2014 – Present

CINRG. Lisinopril vs. Coq10. 2012 – Present

CINRG. Natural History of Duchenne Muscular Dystrophy. 2009 – Present

06/08/2017 6

Neuromuscular Grant, Funded by Wesley Neurology Clinic - $42,000 annually - renewable. 2005 –

Present

Impact of the BETACONNECT auto-injector on BETASERON therapy adherence- Bayer

Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping- CINRG

Bioimpedance as a marker for juvenile myopathies. – Not funded

Bioimpedance as a Marker for Neuromuscular Diseases- Not funded

6 Minute Walk as a Predictor of Loss of Mobility in Amyotrophic Lateral Sclerosis

Longitudinal Study of the Relationship Between Impairment, Activity Limitation, Participation and

Quality of Life in Persons with Confirmed Duchenne Muscular Dystrophy (DMD)

Multicenter Study of Insulin Pump in Diabetes, co-investigator. Principal Investigator: Abbas

Kitabchi, M.D., Department of Endocrinology, University of Tennessee, Memphis, NIH Grant.

Multicenter Drug Trials in Muscular Dystrophy. Funded by the Muscular Dystrophy Association -

$1500 per patient trial

Clinical Trials in Duchenne Muscular Dystrophy, Funded by the Muscular Dystrophy Association -

$20,000 annually - renewable

Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping

3,4-diaminopyridine (3,4-DAP) for Compassionate Use in Lambert Eaton Myasthenic Syndrome

(LEMS)

International GBS Outcome Study (IGOS): A prospective INC study on clinical and biological

predictors of disease course and outcome in GBS

Sareta Exon Skipping Duchenne Muscular Dystrophy 2014

Rasagiline in ALS. Possible mitochondrial target engagement in an open label trial of rasagiline for

ALS. Macchi Z1, Wang Y1, Moore D2, Katz J2, Saperstein D3, Walk D4, Simpson E5, Genge A6,

Bertorini T7, Fernandes J8, Swenson A9, Elman L10, Dimachkie M1, Herbelin L1, Miller J1, Lu J1,

Chellamuthu K1, Swerdlow RH1, Barohn RJ1, & the Western ALS Rasagiline Study Group1-10

CINRG pilot trial coenzyme Q10 in steroid-treated Duchene muscular dystrophy

The cooperative international neuromuscular research group Duchenne natural history study—a

longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods

used. McDonald CM, Henricson EK, Abresch RT, Han JJ, Escolar DM, Florence JM, Duong T,

Arrieta A, Clemens PR, Hoffman EP, Cnaan A; Cinrg Investigators. Muscle Nerve. 2013 Jul;

48(1):32-54. Doi: 10.1002/mus.23807. Epub 2013 May 16

The cooperative international neuromuscular research group Duchenne natural history study:

glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of

disease progression as measured by manual muscle testing and other commonly used clinical trial

outcome measures. Henricson EK, Abresch RT, Cnaan A, Hu F, Duong T, Arrieta A, Han J, Escolar

DM, Florence JM, Clemens PR, Hoffman EP, McDonald CM; CINRG Investigators. Muscle Nerve.

2013 Jul: 48 (1): 55-67. Doi: 10. 1002/mus.23808. Epub 2013 May 6

CINRG Lisinopril, Department of Defense, $375,598. 2012-2014

Questcor Acthar in ALS. 2012-2014

Rasagiline in ALS, University of Kansas, Trial of Safety and Efficacy of Rasagiline in Subjects with

Amyotrophic Lateral Sclerosis. 2012

Muscular Dystrophy Association, $20,000

Trial of 3-4 Aminopyridine in Motor Neuron Diseases, 2003 – November 2007. Methodist Hospital

Foundation. $25,000

Nationwide Clinical Trial for Quantitative and Manual Muscle Testing Measures of Strength in

Children – Funded by Children’s National Medical Center, Washington, DC

9/01/02 – 01/03/03 - $5,000.00 – renewable

Neurological Grant from Wesley Neurology Clinic, $3,500.00 monthly, 42,000 per year. 1996-2005

MRI of muscle in primary myopathy. Tulio E. Bertorini, M.D. (P.I.) Collaboration with H.

Halford and A. Graves, 2002-2003

06/08/2017 7

Radionucleotide scanning in exercised muscle in muscular dystrophy. Collaborative study with Judy

Griffin, P.T., and S. Moinuddin, M.D. Baptist Hospital Foundation, 1996 -2000. $20,000

MRI scanning of muscle in neuromuscular disorders. A collaborative study with H. Halford, M.D.

and A. Graves, M.D. Methodist Hospital Foundation.2000-2002. Not funded

Radioisotope scanning after exercise in neuromuscular atrophy. Tulio E. Bertorini, M.D. (P.I.)

Collaboration with Judy Griffin, PT, and Dr. M. Moinuddin, 2000-2001. Not funded.

"The Use of Mexiletine in the Symptomatic Treatment of Patients with Painful Diabetic

Neuropathies". Collaborating with Drs. William Green (Methodist Hospitals) and Joseph Fisher

(Endocrinology). 2003-2004. Not funded

"Clinical and Quantitative Electrophysiologic Evaluation of Myotonia and its Response to

Treatment". Tulio E. Bertorini, MD (P.I.), Pushpa Narayanaswami, MD and Bob Lobo, PharmD,

July 1999 - 2002. Not funded

A Phase III Open-Label Extension Study of the Long-Term Safety of Recombinant Human Nerve

Growth Factor (rhNGF) in the Treatment of Subjects with Diabetic Neuropathy. Principal

Investigator. October 1998 – June 1999. Not funded

"Muscular Dystrophy and Calmodulin", Harry W. Jarrett, PhD, John Foster, PhD, Tulio E.

Bertorini, MD. Muscular Dystrophy Association, 2000. $25,000

"The Use of Mexiletine in the Symptomatic Treatment of Patients with Painful Diabetic

Neuropathies". Collaborating with Drs. William Green (Methodist Hospitals) and Joseph Fisher

(Endocrinology). 1995 to August 1997. Not funded

"Effects of Diltiazem in the Treatment of Subcutaneous Calcinosis in Dermatomyositis" (1990).

Tulio E. Bertorini, M.D., Genaro M.A. Palmieri, M.D., Jeno I. Sebes, M.D., Jim Karas and R.

Brown-$36,000. Study terminated April 30, 1997

ATP/ADP Translocator Studies, David Nelson (P.I.) 1996 -2003

Calcium Mediated Cell Damage in ALS, Anton Reiner, Ph.D. (P.I.) 1996

"Muscular Dystrophy and Calmodulin." Harry W. Jarrett, Ph.D., John Foster, Ph.D., Tulio E.

Bertorini, M.D. Funded by the Muscular Dystrophy Association, January 1993 – December 1995.

"Effect of the Somatostatin Analog SMS 201-995 in Duchenne Muscular Dystrophy" - Muscular

Dystrophy Association:

12/1/87 - 11/30/88 - $74,710.00

WARRS Study, Kenneth Gaines, M.D. (P.I.)

"Therapeutic Trials in Duchenne Muscular Dystrophy. Pilot Studies using Maneuvers Aimed to

Correct Muscle Calcium Accumulation and Magnesium Depletion" - Neurosurgical Group

(Bertorini):

10/1/87 - 9/30/88 - $14,400.00

"Therapeutic Trials in Duchenne Muscular Dystrophy. Pilot Studies Using Maneuvers Aimed to

Correct Muscle Calcium Accumulation and Magnesium Depletion" - Muscular Dystrophy

Association:

10/1/85 - 9/30/86 - $32,616.00

10/1/86 - 9/30/87 - $45,143.00

"Effect of Diltiazem in Duchenne Muscular Dystrophy" - Muscular Dystrophy Association:

8/1/81 - 7/31/82 - $36,414.00

8/1/82 - 10/31/83 - $47,214.00

11/1/83 - 10/31/84 - $33,253.00

Training Fellowship Grant, Dr. M. Shamlou, July 1980 - June 1981, $18,000.00, Muscular

Dystrophy Association

Training Fellowship Grant, Dr. E. Niakan, July 1979 - June 1980, $18,000.00, Muscular Dystrophy

Association

Member of Dr. Christopher Clark's Multicenter study on polymyositis-dermatomyositis, previously

approved by the Muscular Dystrophy Association. The Elliott Neurological Center of the

Pennsylvania Hospital, Philadelphia, PA

06/08/2017 8

"Effect of Calcium on ATP Content in Turnover in Cultured Duchenne Dystrophy Cells" - Muscular


7/1/85 - 6/30/86, - $40,000.00

"The Disordered Adenine Nucleotide Degradation in Duchenne Muscular Dystrophy" - Muscular


7/1/78 - 6/30/79 - $22,230.00

7/1/79 - 6/30/80 - $22,037.76

7/1/80 - 6/30/81 - $41,331.68

7/1/81 - 6/30/82 - $43,442.46

7/1/82 - 6/30/83 - $33,481.95

7/1/83 - 6/30/84 - $40,000.00

ABSTRACTS

Yambem, O., Bertorini, T., Shadle, M., Differentiation Between Autoimmune Myopathy and

Muscular Dystrophies: submitted for presentation AANEM Annual Meeting 2017.

Ly H, Zhang L, Ferrante MA, Bertorini TE. The neuromuscular feature for light chain deposit

myopathy. Presented at the Annual AANEM meeting. Savannah, GA 2014. Muscle and Nerve Vol.

50, No. 4 p. 671, and presented at The AAN meeting, Washington, DC 2015.

Shen L, Bertorini TE, Ferrante M. A case report of MMN with unusual clinical features. AANEM

meeting, Honolulu, Hawaii, 2015, and presented at The AAN meeting, Washington, DC 2015.

Shen L, Bertorini TE. Inclusion body myositis, analysis of 25 cases AANEM meeting. Honolulu,

Hawaii, 2015.

A Randomized, Double-blind, Placebo-controlled, Phase III, Multi-center Study to Evaluate the

Safety and Efficacy of Eculizumab in Subjects with Refractory Generalized Myasthenia Gravis:

REGAIN. Presented at the Muscle Study Group Meeting. Snowbird, UT 2015.

Porras A., Bertorini TE, Duenas V., Late-Onset Myasthenia Gravis. Presented at the ANA Annual

Meeting. Chicago, IL 2015.

2nd Quarter 2015 The Mid-South Parkinson’s Support Group Newsletter. Management of

Orthostatic Hypotension in Patient’s with Parkinson’s Disease.

Ganta K, Ly H, Bertorini, TE. An unusual presentation of Inclusion Body Myositis. Presented at

the Annual AANEM meeting. Savannah, GA 2014. Muscle and Nerve Vol. 50, No.4 p.668.

Ly H, Bertorini TE. A comparison of the diagnosis findings of electromyography, cloud study and

muscle biopsy. Presented at the Annual AANEM meeting. Savannah, GA 2014. Muscle and Nerve

Vol. 50 No. 4 p. 671.

2013 National Association of Neurology Puerto Rico. Autoimmune Neuropathies.

2013 National Association of Neurology Puerto Rico. Autoimmune Myopathies.

August 29, 2013. Guest Speaker Universidad Nacional de Puerto Rico. Advances in Muscular

Dystrophy

August 20, 2013. Visiting lecturer, Universidad Herminio Valdizan, Huanuco Peru PAMS

Convention. Treatment and management of Multiple Sclerosis.

Advances in multiple sclerosis. PAMS Meeting, August 2013.

The past, present, and future of Alzheimer’s disease in International Neuropsychiatry Course in the

Peruvian School of Medicine (Colegio Medico del Peru). Lima, March 2013.

S. Mansoor, TE Bertorini, C. Pendley. Limb Hemiatrophy in Becker Muscular Dystrophy. Case

report presented 10-5-12. 7th Annual AANEM Meeting, Orlando, FL 2012.

TE Bertorini, C. Pendley, S. Mansoor. Electromyographic Artifacts Produced by a Subthalamic

Nucleus Stimulator. Case Report. Presented 10-5-12 at 7th Annual AANEM Meeting. Orlando, FL.

TE Bertorini. 23rd International Symposium on ALS/MDL. 12-5 to 7-12. Chicago, IL, ALS. Les

Turner Foundation.

06/08/2017 9

C Pendley, S Mansoor, TE Bertorini. Myotonic Dystrophy Type 2 with Electrical Myotonia and

without Weakness. Presented at the AANEM Meeting. Orlando, FL 2012.

McGrew, Charlton, Sims, Bertorini. Successful use of CRT-D in a patient with DMD. Presented at

the Heart Failure Society of America, September 2011.

O’Carroll PJ, Bertorini TE, Chai Y, Maccarino S, Shadle M, (University of Tennessee Health

Science Center). Correlation between IPA cloud results on EMG and contralateral muscle biopsies.

Presented at the AANEM, San Diego, CA, 2010.

Bertorini TE. Motor Unit Quantitation. American Association of Electrodiagnostic Medicine

(AAEM) Workshop, Providence, RI, September 2009.

Tulio E. Bertorini, MD. Polymyositis/Dermatomyositis. Presented at the Peruvian American

Medical Society, XXXVI Annual Convention, Ica, Peru, September 23 – 27, 2009.

Tulio E, Bertorini, MD. New Advances in Muscular Dystrophy. Multispecialty International

Medical Conference, Universidad Ricardo Palma, Lima, Peru, September 2009.

Tulio E. Bertorini, MD. Newest genetic Classification of Muscular Dystrophies and Their

Pharmacologic Management. Presented at the USC International Neuromuscular Symposium,

“Newest Advances in Neuromuscular Diseases – in honor of W. King Engel and Valerie Askanas,

Los Angeles, CA, January 2009.

Tulio Bertorini, MD, Christopher Mitchell, MD, Yingjun Li. Limb edema and anasarca associated

with severe dermatomyositis: Four case reports. Submitted to AANEM, Providence, RI, September

17 – 20, 2008.


(AAEM) Workshop, 2008.

Davonna S. Ledet, MS, Rupert Handgretinger, MD, Tulio E. Bertorini, MD, Gregory A. Hale, Raul

C. Ribeiro, MD and Raja B. Khan, MD. Leucoencephalopathy, Transverse Myelopathy, and

Peripheral Neuropathy in Association with Glutamic Acid Decarboxylase-65 Antibodies in Children

with Cancer. Journal of Child Neurology. J. Child Neurology 2008; 23; 1357 originally published

online May 12, 2008.

Mitchell C, Bertorini TE. The utility of TLI and US in the diagnosis of CTS in patients with CMT.

Presented at the AAEM meeting in Phoenix, Arizona, October 2007.


(AAEM) Workshop, Phoenix, AZ, October 2007.

Mitchell C, Bertorini TE. Diffusely increased insertional activity: “EMG disease” or asymptomatic

myotonia congenita? A report of 2 cases. Presented at the AAEM meeting in Phoenix, Arizona,

October 2007. Published in Arch Phys Med Rehabil. 2007 Sep;89(9):1212-1213.

Bertorini TE, Maccarino S, Holt A. Medial Antebrachial Cutaneous Nerve Neuropathy Secondary

to Dialysis Displacement. Presented at the 53rd Annual Meeting, AANEM, Washington, DC.

October 2006. Published in Muscle Nerve, 34(4); 2006, p 514.


(AAEM) Workshop, Washington, DC, October 2006.

Li Y, Maccarino S, Rashed H, Bertorini TE. Abnormalities in Mixed Nerve Study in Patients with

Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy, presented at the 53rd Annual Meeting,

AANEM, Washington, DC. October 2006. Published in Muscle Nerve, 34 (4): 2006, p 527.

Dunckley T, Huentelman MJ, Craig DW, Pearson JV, Szelinger S, Joshipura K, Halperin RF,

Stamper C, Jenson KR, Letizia D, Hesterlee SE, Pestronk A, Levine T, Bertorini T, et al. Whole-

Genome Analysis of Sporadic Amyotrophic Lateral Sclerosis. Presented in the ALS-MND meeting

in Okinowa, Japan, 2006. Published in N Engl J Med. 2007;357: 775-788.

Jessen K, Maccarino S, Bertorini TE. People with Charcot-Marie Tooth Type II are predisposed to

Median Neuropathy at the Wrist. 57th. Annual Meeting of American Academy of Neurology.

Miami, Fl., April 9-16, 2005, Neurology, 64 (6) S I, A174.



06/08/2017 10

Owens WE, Bertorini TE. Central Nervous System Demyelination in a patient presenting with

Guillain-Barre Syndrome. Muscle & Nerve, 30 (4) Oct, PP 518, 2004.



Bertorini, TE. Fatigue in neuromuscular disorders. Puerto Rico Academy of Neurology, October

2004.

Escolar, D, G Buyse, E. Henricson, J. Florence, J. Meyhew, B. Leshner, MD, C. Tesi-Rocha K.

Gorni, L. Pasquali, Z. Nanjiani, K Patel, R. McCarter, and the CINRG investigators. Creatine and

Glutamine therapeutic trial in Duchenne muscular dystrophy (DMD) by the Cooperative

International Neuromuscular Research Group (CINRG). Presented as a Work in Progress at the

128th American Neurological Association Annual Meeting. San Francisco, CA October18-22, 2003

(all CINRG PIs are in the poster with name and affiliation including Dr. Tulio Bertorini. Abstract #

172.

Bertorini T. “Criterios Diagnostics de ELA”, Presented at the XI Pan American Congress of

Neurology, Santiago, Chile, October 8-11, 2003.

Bertorini T, Gupta D. Cloud Analysis and Correlation to Muscle-Nerve Biopsies in Neuromuscular

Disease. Presented at the annual meeting of the American Association of Electrodiagnostic Medicine

(AAEM), San Francisco, CA, September 2003. Muscle & Nerve supplement 12: S67, 2003.

Bertorini TE, “MUAP Quantitation” Workshop at the AAEM Annual Scientific Meeting in San

Francisco, California, September 16-20, 2003

Owens WE, Gupta D, Bertorini TE. “Enhancement of Contra-Lateral Ptosis. Presented at 50th

Scientific AAEM, San Francisco, California, 2003.

Bertorini TE. Review: Mexitil Monograph Review. American Society of Health Systems

Pharmacists. July 2003.

Bertorini T, Gupta D. Myasthenia-Like Enhancement of Contralateral Ptosis in Mitochondrial

Myopathy. Presented at the annual meeting of the American Association of Electrodiagnostic

Medicine (AAEM), San Francisco, CA, September 2003. Muscle & Nerve supplement 12: S74,

2003.

Bertorini TE. Muscular dystrophies. Presented at the 1st International Conference of Medical

Schools. Lima, Peru. November 2002.

Bertorini TE. Painful Neuropathies. Presented at the 1st International Conference of Medical


Bertorini TE. Autoimmune Neuropathies. Presented at the 1st International Conference of Medical


Bertorini TE. Neuromuscular Channelopathies. Presented at the 1st International Conference of

Medical Schools. Lima, Peru. November 2002.

Bertorini TE. The contribution of the neurological institute to neuromuscular disorders. Presented at

the New York Neurological Institute, Columbia University, New York, NY, November 2002.

Bertorini TE. Evaluation and treatment of painful neuropathies. Presented at the New York Medical

College, New York, NY, November 2002.

Bertorini TE. Painful Neuropathies. Presented at the Metropolitan Hospital, New York, NY,

November 2002.

Bertorini T. Motor Unit Quantitation. Presented at the annual meeting of the American Association

of Electrodiagnostic Medicine (AAEM) Workshop, Toronto, CA, October 2002. Muscle & Nerve

2002.

Ahmed SN, Narayanaswami P, Bertorini TE. Troponin levels in patients with muscle diseases.

Presented at the annual meeting of the American Association of Electrodiagnostic Medicine

(AAEM), October 2002 in Toronto, Canada. Muscle & Nerve 2002.

Eisenberg I Grabov-Nardini G, Hochner H, Potikha T, Askanas V, Bertorini T, Bradley W, Karpati

G, Merlini L, Sadeh Argov Z, Mitrani-Rosenbaum S. Various forms of quadriceps sparing myopathy

06/08/2017 11

are caused my mutations UDP-N-acetylglucosamine 2-epimerase/ N-acetylmannnosamine kinase.

European Human Genetics Conference. Strasbour, 2002.

Eisenberg I Grabov-Nardini G, Hochner H, Sadeh M, Bertorini T, Bushby K, Castellan C, Felice K,

Mendell J, Merlini L, Schilling C, Argov I, Mitrani-Rosenbaum S. Worldwide quadriceps sparing

myopathy is caused by a variety of mutations in the UDP-N-acetylglucosamine 2-epimerase/ N-

acetylmannnosamine kinase gene. Xth International Congress on Neuromuscular Diseases,

Vancouver, 2002.

Eisenberg I Grabov-Nardini G, Hochner H, Sadeh M, Bertorini T, Bushby K, Castellan C, Felice K,

Mendell J, Merlini L, Schilling C, Argov I, Mitrani-Rosenbaum S. Worldwide quadriceps sparing

myopathy is caused by a variety of mutations in the UDP-N-acetylglucosamine 2-epimerase/ N-

acetylmannosamine kinase gene. American Academy of Neurology. April 2002.

Bertorini TE. Motor Unit Quantitation. Presented at the annual meeting of the American

Association of Electrodiagnostic Medicine (AAEM) Workshop, Albuquerque, NM, October 2001.

Muscle & Nerve 10, 2001.

Kumar KS, Bertorini T, Igarashi M, Narayanaswami P. Familial Dermatomyositis. Presented at the

annual meeting of the American Association of Electrodiagnostic Medicine (AAEM), Albuquerque,

NM, October 2001. Muscle & Nerve 10, 200l.

Bertorini TE. Motor Unit Quantitation. Presented at the annual meeting of the American

Association of Electrodiagnostic Medicine (AAEM) Workshop, Philadelphia, PA, September 2000.

Muscle & Nerve 23(10)2000.

Narayanaswami P, Bertorini TE. Symmetric pure motor neuropathy with conduction blocks. The

missing link? Presented at the annual meeting of the American Association of Electrodiagnostic

Medicine (AAEM), Philadelphia, PA, September 2000. Muscle & Nerve 23(10):1626, 2000.

Senthilkumar K, Narayanaswami P, Bertorini TE. Amyotrophic lateral sclerosis or not? Diagnostic

pitfalls. Presented at the annual meeting of the American Association of Electrodiagnostic Medicine

(AAEM), Philadelphia, PA, September 2000. Muscle & Nerve 23(10):1637, 2000.

Bertorini TE, Narayanaswami P, Senthilkumar K, Horner L. “Clasp Knife” myopathy. Presented at

the annual meeting of the American Association of Electrodiagnostic Medicine (AAEM),

Philadelphia, PA, September 2000. Muscle & Nerve 23(10):1638, 2000.

Narayanaswami P, Bertorini TE, Palmieri GMA, Igarashi M, Carbone L. Dual Energy X-Ray

Absorptiometry (DEXA) in the Evaluation of Patients with Muscular Diseases: Correlation with

Disease Progression and Steroid Therapy. Presented at the annual meeting of the American

Academy of Neurology, May 2000, San Diego, CA, Neurology 54(7): S3:A270, 2000.

Narayanaswami P, Maccarino S, Bertorini TE, Naqvi Y, Horner L. New Method of Studying

Peroneal Nerve Using the Extensor Hallucis Longus Muscle. Presented at the annual meeting of the

American Association of Diagnostic Medicine, October 1999, Vancouver, BC, Canada. Muscle &

Nerve 1999; 22 (9): 1332.


(AAEM) Workshop, Vancouver, Canada, October 1999.

Khan, RB, Callahan T, Levin MC, Bertorini TE. Recurrent Inflammatory Myopathy, T-cell

Lymphoma, and Human T-cell Lymphotrophic Virus, type I in an African American. Presented at

the 46th Annual Scientific Meeting of the American Association of Electrodiagnostic Medicine,

Vancouver, Canada, October 1999. Muscle & Nerve 1999; 22 (9), 1332.

Narayanaswami P, Bertorini TE, Frederick R. Gastric Bypass Neuropathy: Clinical,

Electrophysiologic/Histologic Correlates. Presented at the American Association of

Electrodiagnostic Medicine, October 1999, Vancouver, BC, Canada. Muscle & Nerve

1999;22(9):1332.

Bertorini TE, Narayanaswami P, Horner L. Kennedy's Disease Presenting as Sporadic Spinal

Muscular Atrophy. Presented at the American Association of Electrodiagnostic Medicine, October

1999, Vancouver, BC, Canada. Muscle & Nerve 1999;22(9):1336.

06/08/2017 12

Naqvi Y, Narayanaswami P, Bertorini TE, Horner L. Proximal Myotonic Myopathy Presenting as

Limb Girdle Dystrophy. Presented at the American Association of Electrodiagnostic Medicine,

October 1999, Vancouver, BC, Canada. Muscle & Nerve 1999;22(9):1326-1327.

Giuliani MJ, Litchy WB, Rohrer M, Compton P, Dyck PJ, NGF Study Investigators. rhNGT in the

treatment of diabetic peripheral baseline characteristics from a phase III clinical study. Neurology

52(6): A552, 1999.

Giuliani MJ, Litchy WB, Rohrer M, Compton P, Dyck PJ, NGF Study Investigators. rhNGT in the

treatment of diabetic peripheral baseline characteristics from a phase III clinical study. Presented at

the annual meeting of the American Academy of Neurology, April 1999 in Toronto, Ontario,

Canada. Neurology 52(6): A552, 1999.

Vinik A and the NGF Study Investigators. Treatment of diabetic polyneuropathy (DPN) with

recombinant human nerve growth factor (rhNGF). ADA, 1999.

Dyck PJ, Litchy WB, Rask C, Bergstrom B and NGF Study Investigators. Diabetic peripheral

neuropathy: design of a ground-breaking phase III clinical study. Presented at the annual meeting of

the American Academy of Neurology, April 1999 in Toronto, Ontario, Canada. Neurology 52(6):

A129, 1999.

Grant IA, Dyck PJ, Harper M and NGF Study Investigators. Paraspinal muscle denervation in

diabetic polyneuropathy. Presented at the annual meeting of the American Academy of Neurology,

April 1999 in Toronto, Ontario, Canada. Neurology 52(6): A382, 1999.

Workshop, October 1998.

Bertorini TE, Boxman JR. A Simple Novel Device to Standardize Vibratory Sense Testing at the

Bedside. Presented at the 45th Annual Scientific Meeting of the American Association of

Electrodiagnostic Medicine on October 1998 in Orlando, FL. Muscle & Nerve Nov 1998, p. 1592.

Bertorini TE, Alzagatiti BI, Horner LH, Maccarino VS. Clinical and Electrophysiological Effects

of Mexiletine in Painful Neuropathy. Presented at the 45th Annual Scientific Meeting of the

American Association of Electrodiagnostic Medicine on October 1998 in Orlando, FL. Muscle &

Nerve 21 (11), 1998.

Boxman JR, Bertorini TE, Arnold TW. Stiff-person Syndrome and Myasthenia Gravis Without

Thymoma. Presented at the 45th Annual Scientific Meeting of the American Association of

Electrodiagnostic Medicine on October 1998 in Orlando, FL. Muscle & Nerve 21 (11), 1998.

Narayanaswami P, Khan RB, Bertorini TE. Progressive Amyotrophy as a Late Complication of

Transverse Myelopathy. Presented at the 45th Annual Scientific Meeting of the American

Association of Electrodiagnostic Medicine on October 1998 in Orlando, FL, Muscle & Nerve

21(11):1603, 1998.

Bertorini TE, Sebes JI, Palmieri GMA, Igarashi M, Horner LH. Diltiazem in the Treatment of

Calcinosis in Juvenile Dermatomyositis. Presented at the 50th Annual Meeting of the American

Academy of Neurology on April 29, 1998, in Minneapolis, MN. Published in Neurology 50(S4):

A204, 1998.

Varelas PN, Bertorini TE, Halford H. Bilateral Ophthalmoplegia Complicating Central

Hemodialysis Catheter Placement. Presented at the 50th Annual Meeting of the American Academy

of Neurology on April 30, 1998, in Minneapolis, MN. Published in Neurology 50(S4): A333, 1998.

Bertorini TE. Diagnosis and Treatment of Neuropathies. Presented at Neurology Update for the

Primary Care Physicians, a conference sponsored by Methodist Healthcare on August 15, 1998, in

Memphis, TN.

Bertorini TE. Ancient Peruvian Medicine. Presented at Neurology Update for the Primary Care

Physicians, a conference sponsored by Methodist Healthcare on August 15, 1998, in Memphis, TN.


(AAEM).

Boxman JR, Bertorini TE, Kraus A, O’Brien TF. Uremic “Myopathies”: Unusual Causes of

Proximal Weakness in Uremia. Presented at the 50th Annual Meeting of the American Academy of

Neurology on April 28, 1998, in Minneapolis, MN. Published in Neurology 50(S4): A124, 1998.

06/08/2017 13


(AAEM) Workshop, October 1997.

Bertorini TE, Horner LH. Myosin-stained paraffin sections in the evaluation of neuromuscular

disease. Presented at the annual meeting of the American Association of Electrodiagnostic Medicine

in San Diego, California, September 19, 1997. Published in Muscle Nerve 20:1067, 1997.

Alzagatiti BI, Moinuddin M, Horner LH, Bertorini TE. Radioisotope scanning in muscle necrosis.

Presented at the annual meeting of the American Association of Electrodiagnostic Medicine in San

Diego, California, September 19, 1997. Published in Muscle Nerve 20:1067, 1997.

Alzagatiti BI, Bertorini TE, Horner LH, Maccarino VS. Focal Myositis Presenting with Radial

Nerve Palsy. Presented at the annual meeting of the American Association of Electrodiagnostic

Medicine in San Diego, California, September 19, 1997. Published in Muscle Nerve 20:1064, 1997.

Nymann T, Hathaway DK, Shokouh-Amiri MH, Bertorini TE, Gaber AO. Improvement in

peripheral neuropathy following kidney (K) and simultaneous pancreas-kidney (SPK)

transplantation. Presented at the annual meeting of the American Society of Transplant Physicians

on May 11, 1997, Chicago, IL.


(AAEM) Workshop, Minneapolis, October 1996.

Almsaddi M, Bertorini TE, Bastnagle W. Remission Myasthenia Gravis Caused by Proteinuria in

Nephrotic Syndrome. Presented at the annual meeting of the American Association of

Electrodiagnostic Medicine, October 1996, Minneapolis, MN. Published in Muscle Nerve

19(9):1202, 1996.

Schweizer V, Woodson GE, Allegretti JP, Bertorini TE. Single Fiber Electromyography in the

Normal Larynx. Preliminary Studies. Presented to the American Association of Electrodiagnostic

Medicine, Minneapolis, MN, October 4, 1996. Published in Muscle Nerve 19(9):1192-1193, 1996.

Bertorini TE, Horner LH, Halford H III. Characteristics of Magnetic Resonance Imaging (MRI) in

Limb and Axial Weakness in Myopathies. Presented at the annual meeting of the American

Academy of Neurology, March 1996. Neurology 46(2) S: A345, 1996.

Siddiqui M, Bertorini T. Hypophosphatemia-induced neuropathy: Electrophysiologic and clinical

findings. Presented at the AAEM Annual Meeting, Montréal, Canada, September 23, 1995.

Published in Muscle & Nerve 18(9):1069, 1995.

Bertorini TE, Subramony S, Ward J, Vedanarayanan V, Fratkin J, Gordon P. Distal muscular

dystrophy with electrical myotonia mimicking myotonic dystrophy. Presented at the AAEM Annual

Meeting, Montréal, Canada, September 23, 1995. Published in Muscle & Nerve 18(9):1052, 1995.

Khan AU, Bertorini TE. Granulomatous myositis with tongue involvement resembling

amyotrophic lateral sclerosis. Presented at the AAEM Annual Meeting, Montréal, Canada,

September 22, 1995. Published in Muscle & Nerve 18(9):1041, 1995.

Bertorini TE, Halford H. Selected paraspinal amyotrophy with normal limbs-magnetic resonance

imaging, EMG and biopsy findings. Presented at the AAEM Annual Meeting, September 22, 1995.

Published in Muscle & Nerve 18(9):1046, 1995.

Bertorini TE, Nance AM, Horner LH, Jaster JH. Complications of Intravenous Gamma Globulin

Infusion in Neuromuscular Diseases. Presented at the American Academy of Neurology Annual

Meeting, May 10, 1995, Seattle, WA. Published in Neurology 45(S4): 265P, 1995.

Griffin, JW, Bertorini TE, O'Toole ML, Tolley EA, Tooms RE. Isokinetic assessment of muscle

performance in patients with inflammatory myopathy. Presented at the Second Joint American

Physical Therapy Assoc/Canadian Physiotherapy Assoc Joint Congress in Toronto, Canada, June 7,

1994.

Bertorini TE. Inflammatory neuropathies. Presented at the Neuromuscular Diseases Symposium,

Universidad de Venezuela, Barquisimeto, Venezuela, 1994.

Bertorini TE. Metabolic myopathies. Presented at the Neuromuscular Diseases Symposium,

Universidad de Venezuela, Barquisimeto, Venezuela, 1994.

06/08/2017 14

Bertorini TE. Guillain-Barré Syndrome and chronic inflammatory neuropathies. Presented at the

Neuromuscular Diseases Symposium, Universidad de Venezuela, Barquisimeto, Venezuela, 1994.

Dias P, Bertorini T, von Wronski MA, Houghton P, Horner L, Holt H, Nance A and Parham D.

MyoD1 immunostaining of skeletal muscle in primary myopathies and neurogenic atrophies.

Presented at the Griffin, JW, Tooms RE, Vander Zwaag R, Bertorini TE, O'Toole ML.

Eccentric/concentric muscle performance in patients with upper motor neuron disorder. Presented to

the American College of Sports Medicine in Seattle, Washington, June 2-5, 1993. Medicine and

Science in Sports and Exercise 25(5) S43, 1993.

Vo DT, Bertorini T, Lawrence J, Halford H, Wassef M. Gadolinium enhancement of MRI signal in

patients with chronic inflammatory demyelinating neuropathy (CIDP). Presented to the American

Academy of Neurology 1993 Annual Meeting held in New York April 27 - May 1, 1993.

Annual Meeting of the United States and Canadian Academy of Pathology in New Orleans, LA,

March 16, 1993, published in Modern Pathology 6:120A (#699), 1993.

Griffin, JW, O'Toole ML, Vander Zwaag R, Bertorini TE, Tooms RE. Eccentric and concentric

torque of elbow and knee muscle groups in healthy men and women. Presented at the American

College of Sports Medicine Annual Conference, May 1992. Published in Med Sci Sports Exerc 24:

S164, 1992.

Palmieri G, Nutting D, Bittle J, Edwards M, Sacks H, Schriock E, Bertorini T. Octreotide, an

inhibitor of growth hormone secretion, enhances positive calcium balance in children. Presented at

the XIth International Conference on Calcium Regulating Hormones, Florence, Italy, April 24-29,

1992. Published in Bone and Mineral Abstracts, 1992.

Bertorini TE. Inflammatory Neuropathies. Presented at the Thirteenth Peruvian Congress of

Neurology, Lima, Peru, South America, October 1991.

Bertorini TE. Polymyositis/Dermatomyositis - New Developments. Presented at the Thirteenth

Peruvian Congress of Neurology, Lima, Peru, South America, October 1991.

Bertorini TE. Histological Basis of EMG. Presented at the Thirteenth Peruvian Congress of

Neurology, Lima, Peru, South America, October 1991.

Bertorini TE. New Developments in Duchenne Muscular Dystrophy. Presented at the Pan

American Congress of Neurology, Montevideo, Uruguay, South America, October 1991.

Bertorini TE. Advances in Inflammatory Myopathies. Presented at the Regional Congress of

Neuromuscular Diseases, Buenos Aires, Argentina, South America, October 1991.

Bertorini TE. Therapy in Duchenne Muscular Dystrophy. Presented at the Regional Congress of

Neuromuscular Diseases, Buenos Aires, Argentina, South America, October 1991.

Gaber AO, Bertorini T, Cardosa S, Abell T, Hathaway D, Pearson S. Neuropathic improvement

following pancreas-kidney (P-K) transplantation. Submitted to the Third International Congress on

Pancreatic and Islet Transplantation Symposium on Artificial Insulin Delivery System, June 6-8,

1991, Lyon, France.

Elsehety AE, Bertorini TE. Neurological complications in Crohn's Disease. Presented at the

annual American Academy of Neurology meeting, Boston, April 1991. Published in the Ann Neurol

Abstracts, 1991.

Palmieri, GMA, Nutting DF, Schriock EA, Bertorini TE, Sacks HS, Bittle JB, Griffin JW,

Elmendorf BJ, Edwards MC. Octreotide, a somatostatin analog, reduces urinary calcium excretion

in children. American Society for Bone and Mineral Research Meeting, 1990.

Law PK, Fang Q, Goodwin TG, Florendo JA, Herrod H, Bertorini T, Kirby DS, Li HJ, Chen M,

Yuan D, Golden GS. First clinical trial of myoblast transfer therapy. Presented to the Society for

Neuroscience, St. Louis, MO, October 28-November 2, 1990.

Bertorini, TE, Schriock E, Palmieri GMA, Griffin JC, Nutting DF, Bittle JB, Sacks HS. Effects of

Somatostatin on Duchenne muscular dystrophy. Presented to the VII International Congress of

Neuromuscular Diseases, Munich, West Germany, September 17-22, 1990.

06/08/2017 15

Nutting DF, Palmieri GMA, Bittle JB, Edwards MC, Sacks HS, Schriock EA, Bertorini TE. Effects

of the somatostatin analog, Octreotide, on calcium metabolism in children with muscular dystrophy.

Southern Society for Clinical Investigation, Chicago, 1990.

Thompson B, Bertorini TE, Laster R. Spontaneous internal carotid artery dissection documentation

by magnetic resonance angiography. American Academy of Neurology, 1990.

Griffin, JE, Bertorini TE. The use of isokinetic dynamometry in the evaluation of neuromuscular

disease. Presented at the American Academy of Electromyography and Electrodiagnostic Medicine

Annual Meeting, September 1989. Published in Electromyogr Clin Neurophysiol 76:41, 1990.

Griffin, J, Bertorini TE. The use of isokinetic dynamometry in the evaluation of neuromuscular

disease. Presented at the Annual Meeting of the American Association of Electromyography and

Electrodiagnosis, Washington, DC, September 1989. Published in Muscle & Nerve, p. 759,

September 1989.

Cardoso SS, Puniani TS, Bertorini TE. Capillary vasomotor function test in the diagnosis of

autonomic neuropathy. Presented at the Annual Meeting of the American Association of

Electromyography and Electrodiagnosis, Washington, DC, September 1989. Published in Muscle &

Nerve, p. 765, September 1989.

Schriock EA, Nutting DF, Sacks HS, Palmieri GMA, Elmendorf J, Bertorini TE. Somatostatin

Analog SMS 201-995 Suppresses Spontaneous and Growth Hormone Releasing Hormone

Stimulated Growth Hormone Secretion in Boys with Duchenne Muscular Dystrophy. Presented at

the Annual Meeting of The Endocrine Society, June 1989, Seattle, WA.

Nutting DF, Bittle JB, Elmendorf BJ, Hooten JC, Griffin JW, Schriock EA, Sacks HS, Palmieri GM,

Bertorini TE. Subacute effects of octreotide in children with muscular dystrophy: II. Nitrogen

balance, blood glucose, and pancreatic hormone secretion. Presented to the Second International

Symposium on Somatostatin, August 6-9, 1989, Montreal, Quebec, Canada

O'Toole ML, Griffin JW, Bertorini TE. The use of sequential cycle ergometry testing in a patient

with dermatomyositis. Presented at the APTA National Conference, 1988. Published in Physical

Therapy 68:851, 1988.

Bertorini TE, Lemmi HE, Arkin C. Polysomnography in idiopathic muscle pain syndrome.

Presented at The American Neurological Association annual meeting, October 2-5, 1988.

Bertorini TE. Histologic studies in muscle of hyperparathyroidism. Presented at the 1st

International Conference on New Actions of Parathyroid Hormone, Kobe, Japan, October 26-31,

1987.

Palmieri GMA, Bertorini TE, Nutting DF, Hinton AB. Parathyroid hormone in muscular

dystrophy. Presented at the 1st International Conference on New Actions of Parathyroid Hormone,

Kobe, Japan, October 26-31, 1987.

Lichstein KL, Fischer SM, Eakin TL, Amberson JI, Bertorini TE, Hoon PW. Physiological

parameters of migraine and muscle contraction headaches. Presented at the 21st Annual Meeting of

the Association for the Advancement of Behavior Therapy, Boston, MA, 1987.

Bertorini TE, Kraus A, Acchiardo S, Pitcock J, Palmieri G, Coleman M, Deneke J. Myopathy

induced by metal accumulation in uremics. Presented at the VIth International Congress on

Neuromuscular Diseases, Los Angeles, CA, July 6-11, 1986.

Bertorini, TE, Brown, R, Griffin, J, Hinton, AB, Igarashi, M, Karas J, McGee JE, Palmieri GMA.

Attempts to correct muscle calcium accumulation in Duchenne muscular dystrophy (DMD).

Presented at the VIth International Congress on Neuromuscular Diseases, Los Angeles, CA, July 6-

11, 1986.

Pillai R, Bertorini TE, Robinson L. Clinical, electrophysiological and histological differences

between inclusion body myositis (IBM) and polymyositis (PM). Presented at the VIth International

Congress on Neuromuscular Diseases, Los Angeles, CA, July 6-11, 1986.

Pillai R, Bertorini TE, Igarashi M, Hannisian A, Pepper B, Grubbs L. Long term follow up studies

in childhood dermatomyositis (ChDM), single fiber EMG (SFEMG) and muscle histochemistry

06/08/2017 16

during remission. Presented at the VIth International Congress on Neuromuscular Diseases, Los

Angeles, CA, July 6-11, 1986.

Bertorini TE, Palmieri GMA, Griffin J, Hinton A, Karas JG. Dantrolene in Duchenne muscular

dystrophy. Clinical Research 34(4):948A, 1986.

Gupta RC, Ringel S, Bertorini TE, Kaplan S. Antibodies to cytoplasmic components in idiopathic

polymyositis. Arthritis Rheumatism 29: S38, #158, 1986.

Clark C, Bertorini TE, Neville H, Miller R, Bender A, Rivner M, Bennett R, Fenichel G, Fischbeck

K, Roses A, McQuillen M, Altman R. Prospective evaluation of treatment in patients with

polymyositis and dermatomyositis. Presented at the Annual Meeting of the American Academy of

Neurology, New Orleans, LA, April 27 - May 3, 1986. Published in Neurology 36(S1):237, 1986.

Ratts, TE, Purgar R, Tayel M, Conway L, Till F, McGee J, Palmieri GMA, Bertorini TE. Effects of

Diltiazem on impaired left ventricular filling in Duchenne's muscular dystrophy. Presented at the

American Heart Association's 58th Scientific Sessions, November 11-14, 1985, Washington, DC.

Bertorini TE, Igarashi M, Hanissian AS. Clinical and histological studies in long term follow up of

childhood dermatomyositis. Presented at the American Academy of Neurology Meeting, Dallas,

Texas, April 1985. Published in Neurology 35(S1):304, 1985.

Palmieri GMA, Bertorini TE, Hinton AB. Parathyroid hormone in Duchenne muscular dystrophy.

Presented at the American Academy of Neurology meeting, Dallas, Texas, April 1985. Published in

Neurology 35(S1):164-5, 1985.

Reimao R, Bertorini TE, Lemmi H. Central apnea in myotonic dystrophy. Presented at the

American Academy of Neurology meeting, Dallas, Texas, April 1985.

Bertorini TE, Palmieri GMA, Fox IH, Bhattacharya SK, Nutting D, Griffin J, Hinton A, Pepper B.

Metabolic studies in muscular dystrophy. Presented at the 20th Anniversary of the Clinical Research

Center, University of Tennessee Center for the Health Sciences, Memphis, TN, 1984.

Mendell JR, Kissel JT, Kennedy MS, Grinvalsky HT, Pittman GL, Kyler RS, Roelofs RI, Whitaker

JN, Bertorini TE. Plasma exchange in acute inflammatory polyradiculo-neuropathy (Guillain-Barré

Syndrome) The Ohio State controlled, randomized trial. Presented at the 6th Annual Apheresis

Symposium "Current Concepts and Future Trends", Chicago, IL, September 20-23, 1984.

Palmieri GMA, Bertorini TE, Bhattacharya SK, Nutting DF, Hinton AB. Muscle calcium

accumulation in muscular dystrophy. Presented at the Satellite Symposium to the 9th International

Congress of Pharmacology Ulm/Neu-Ulm, Fed. Rep. of Germany, August 6-8, 1984. Published in

Cell Calcium 5(3):277, 1984.

Bertorini TE. Clinical trials in Duchenne muscular dystrophy: the experience in Memphis,

Tennessee. Presented at the International Symposium "Muscular Dystrophy Facts and Perspectives",

June 3-4, 1983, Modena, Italy.

Bertorini TE, Bhattacharya SK, Palmieri GMA. Studies of calcium content in muscular dystrophy.

Presented at the International Symposium "Muscular Dystrophy Facts and Perspectives", June 3-4,

1983, Modena, Italy.

Mendell JR, Kissell JT, Kennedy MS, Grinvalsky HT, Pittman GL, Kyler RS, Roelofs RI, Whitaker

JN, Bertorini TE. Plasma exchange in acute inflammatory polyradiculo-neuropathy: a controlled-

randomized trial. Presented at the American Neurological Association Meeting, New Orleans, LA,

1983. Annals of Neurology 14(1):122, 1983.

Bertorini TE. Diagnostic use of histochemical techniques in muscle biopsies. Presented at the

Tennessee Society for Histotechnology, Inc., Memphis, TN, 1983.

Bertorini TE. The diagnosis and classification of neuromuscular disorders - clinical and laboratory

testing. Presented at the American Academy of Cerebral Palsy and Developmental Medicine,

Chicago, IL, 1983.

McGee JE, Bertorini TE, Palmieri GMA, Ratts T. Effect of Diltiazem on cardiac function in

Duchenne muscular dystrophy. Clinical Research 31(2):205a, 1983.

06/08/2017 17

Griffin J, McClure M, Bertorini TE. Isokinetic evaluation in patients with neuromuscular diseases.

Presented at the Annual Meeting of Physical Therapy, San Francisco, CA, June 1982. Published in

Physical Therapy 62:691, 1982.

Bertorini TE, Fox IH, Palmieri GMA, Griffin J, Chesney C, Pifer D. The disordered adenine

nucleotide degradation in Duchenne muscular dystrophy. Presented at the 5th International Congress

on Neuromuscular Diseases, Marseille, France, September 12-17, 1982.

Bertorini TE, Bhattacharya SK, Nutting D, Hinton A, Palmieri GMA. Calcium in muscular

dystrophy. Presented at the 5th International Congress on Neuromuscular Diseases, Marseille,

France, September 12-17, 1982.

Bertorini TE, Griffin J, McClure M. Isokinetic evaluation of muscle strength in patients with

neuromuscular disease. Presented at the 5th International Congress on Neuromuscular Diseases,

Marseille, France, September 12-17, 1982.

Griffin JW, Bertorini TE, McClure MH. Isokinetic evaluation of muscle strength in patients with

neuromuscular disease. Presented at the APTA National Conference, 1982.

Bertorini TE, Bhattacharya SK, Nutting DF, Hinton AB, Palmieri GMA. Calcium in muscular

dystrophy. Presented at the Regional Meeting of ASBMR, Montreal, NC, March 28-30, 1982.

Bertorini TE, Bhattacharya SK, Chesney C, Pifer D, Palmieri GMA. Muscle magnesium in

Duchenne muscular dystrophy and other myopathies. Clinical Research 30:408, 1982.

Whitaker J, Bertorini T, Mendell J. Immunocytochemical studies of cathepsin D in human

dystrophic muscle. Presented at the American Neurological Association, San Francisco, CA,

October 1981. Published in Annals of Neurology, Vol. 9,10, 1981.

Law PK, Bertorini TE. Nerve regeneration and muscle reinnervation. Abstract, Society for

Neuroscience 14th Annual Meeting, Los Angeles, CA, Vol. 7, #153.7, 1981.

Bertorini TE, Bhattacharya SK, Palmieri GMA. Muscle calcium content in Duchenne muscular

dystrophy. Presented at the American Academy of Neurology, Ontario, Canada, May 30, 1981,

Abstract #13. Published in Neurology 31:46, 1981.

Bertorini TE, Fox IH, Palmieri GMA, Edwards L, Griffin J. Allopurinol in muscular dystrophy.

Presented at the International Conference in Allopurinol Therapy in Muscular Dystrophy, New York,

NY, October 13, 1980.

Bertorini TE, Fox IH, Palmieri GMA, Edwards L, Griffin J. The disordered adenine nucleotide

degradation in Duchenne muscular dystrophy. Read at the American Academy of Neurology, April

1980, New Orleans, LA. Published in Neurology 30:403, 1980.

Bertorini TE, Fox IH, Palmieri GMA, Edwards L, Griffin J. The disordered adenine nucleotide

degradation in Duchenne muscular dystrophy. The American Rheumatism Association, Central

Region, Chicago, IL, 1980. Published in Clinical Research 28:786, 1980.

Bhattacharya SK, Palmieri GMA, Bertorini TE, Nutting DF. Calcium in muscular dystrophy. Read

at the VII International Conference on Calcium Regulating Hormones, E. Park, CO, September 5,

1980.

Palmieri GMA, Nutting DF, Bhattacharya SK, Bertorini TE. Parathyroid ablation in muscular

dystrophy. Presented at the annual meeting of the Endocrine Society, Washing, DC June 17, 1980.

Published in Endocrinology 62(S122), 1980.

Koch B, Bertorini TE, Eng G, Boehm R. Diverse presentation of multicore disease. Read at the

American Academy of Physical Medicine and Rehabilitation, San Diego, CA, 1980.

Niakan E, Pitner S, Whitaker J, Bertorini TE. The use of immuno¬suppressive agents in

corticosteroid-refractory childhood dermatomyositis. Read at the American Academy of Neurology

Meeting, Chicago, IL, 1979. Published in Neurology 29:503, 1979.

Engel AG, Lambert EH, Mulder DM, Torres CF, Sahashi K, Bertorini TE, Whitaker JN.

Investigations of three cases of a newly recognized familial, congenital myasthenic syndrome. Read

at the American Neurological Association, St. Louis, MO, 1979. Published in Annals of Neurology

6:146-7, 1979.

06/08/2017 18

Bertorini TE. Histological correlates of electromyographic findings in denervating diseases. Read

at the 2nd Iberoamerican Congress of Electroencephalography and Clinical Neurophysiology, Lima,

Peru, South America, 1979.

Niakan E, Bertorini TE, Lemmi H, Medeiros M, Drewry R, Kish EL. Autosomal dominant

spinocerebellar degeneration and slow saccades: clinical and electrophysiological findings in three

generations of a kindred. Read at the Southern EEG Society, New Orleans, LA, October 1979.

Borer WZ, Bertorini TE, Robertson EA. Studies of Glomerular filtration rate with iodothalamate

1125 in neuromuscular diseases. Read at the American Association for Clinical Chemistry, San

Francisco, CA, 1978.

Bertorini TE, Stalberg E, Yuson C, Engel WK. Correlations of single fiber electromyography

(SFEMG) and muscle histochemistry in 54 patients with neuromuscular diseases. Read at the 24th

Annual Meeting of the American Association of Electromyography and Electrodiagnosis. Published

in the Journal of Electroencephalography and Clinical Neurophysiology 45:20P, 1978.

Adornato BT, Engel WK, Kucera J, Bertorini TE. Benign focal amyotrophy. American Academy

of Neurology, Los Angeles, CA, 1978. Published in Neurology 28:399, 1978.

Brooks BT, Engel WK, Sode J, Diaz M, Bertorini TE. Cyclic nucleotide phosphodiesterase (PDE)

inhibitor therapy with phthalazinol in Amyotrophic Lateral Sclerosis (ALS). Read at the American

Academy of Neurology, Los Angeles, CA, 1978. Published in Neurology 28:402, 1978.

Bertorini TE, Schwartz K, Stadlan E, Martinez V, DiMauro S. Carnitine palmityl transferase

deficiency presenting as acute respiratory muscle failure in a 51-year-old man. IV International

Congress of Neuromuscular Disease, Montreal, Canada, 1978.

Gottdiener JS, Hawley RJ, Marson BJ, Bertorini TE, Engel WK. Hypertrophic cardiomyopathy in

Friedreich's Ataxia. Read at the American Heart Association's 52nd Scientific Sessions, November

1978.

Brumback R, Bertorini TE, Engel WK Oliver KL, Zirzow SC. A comparison of membrane receptor

in myotonia and fibrillation, in vivo. Read at the American Academy of Neurology, Atlanta, GA,

1977. Published in Neurology 27:358, 1977.

Bertorini T, Stalberg E, Engel WK. Histochemical and Physiologic Correlations in Patients with

Type-I Muscle-Fiber Predominance (Type-II Fiber Paucity). Read at the American Academy of

Neurology, Atlanta, GA, April 1977. Published in Neurology 27:358, 1977.

Bertorini TE, Brumback R, Kula R, Engel WK. Electrophysiological and histochemical

observations in 5 patients with muscle phosphorylase deficiency. Read at the American

Neurological Association, Chicago, IL, 1977. Published in the Annals of Neurology, 1977.

Bertorini TE. Nerve conduction velocity in normal Peruvians. Second Peruvian Congress of

Physical Medicine and Rehabilitation, 1970.

Bertorini TE. Carpal tunnel syndrome electrophysiologic diagnosis. Read and published in the

Proceedings of the Peruvian Congress of Rheumatology, 1970.

Bertorini TE. Suprascapular neuropathy as a cause of frozen shoulder. Read and published in the

Proceedings of the Peruvian Congress of Rheumatology, 1970.

PUBLICATIONS

The ALSUntangled Group (2017): ALSUntangled No. 39: Acuscope (micro-Amp electrical muscle

stimulation), Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.

The ALSUntangled Group (2017) ALSUntangled No. 38: L-erine, Amyotrophic Lateral Sclerosis

and Frontotemporal Degeneration, 18:1-2, 148-151.

Bello R., Bertorini T., Mays W., A Man with Distal Asymmetric Leg Weakness; In Press, Journal

of Clinical Neuromuscular Disease.Bart C., Jacob, Bianca van den Berg, Christine Verboon,

Govindsinh Chavada, David R. Cornblath, Kenneth C. Gorson, Thomas Harbo, Hans-Peter Hartung,

Richard A.C. Hughes, Susumu Kuaunoki, Pieter A. van Doorn, Hugh J. Willison and the IGOS

Consortium++; International Guillain-Barre Syndrome Outcome Study (IGOS); Protocol of

06/08/2017 19

Prospective observational cohort study on clinical and biological predictors of disease course and

outcome in Guillain-Barre syndrome; PubMed April 2017.

Bertorini T., Chunga N., Meza K., Esclerosis Multiple; La Revista Sel Paciente Hispano Y El

Medico Del Medio Sur; April 2017 No. 2.

Bello R, Bertorini TE, Ganta K, Mays W “A Case of Asymptomatic Inclusion Body Myositis”

Journal of Clinical Neuromuscular Disorders. 2017 Mar;18(3):132-134.

Porras A., Bertorini T., Duenas V., Mays W., Late Onset Myasthenia Gravis: A review and report

of 24 cases; Pub Status: submitted for review, Journal of Clinical Neuromuscular Disease, Mar

2017.

Hogarth MW, Houweling PJ, Thomas KC, Gordish-Dressman H, Bello L; Cooperative International

Neuromuscular Research Group (CINRG)., Pegoraro E., Hoffman EP, Head SI, North KN.,

Evidence for ACTN3 as a genetic modifier of Duchenne Muscular Dystrophy; Nat Commun 2017

Jan 31; 8:14143.

The ALSUntangled Group (2016) ALSUntangled No. 37: Inosine, Amyotrophic Lateral Sclerosis

and Frontotemporal Degeneration.

The ALSUntangled Group (2016) ALSUntangled No. 36: Accilion, Amyotrophic Lateral Sclerosis


The ALSUntangled Group (2016) ALSUntangled No. 35: Hyperbaric Oxygen Therapy, Amytrophic

Lateral Sclerosis and Frontotemporal Degeneration, 17:7-8, 622-624.

The ALSUntangled Group (2016) ALSUntangled No. 34: GM604, Amyotrophic Lateral Sclerosis


The ALSUntangled Group (2016) ALS Untangled No. 33 Endotherapia, Amyotrophic Lateral

Sclerosis and Frontotemporal Degeneration, 17:5-6, 461-465.

Punetha J., Mansoor S., Bertorini TE., Kesari A., Brown KJ, Hoffman EP., Somatic mosaicism due

to a reversion variant causing hemi-atrophy: a novel variant of dystrophinopathy; Eur J Hum Genet.

2016 Oct;24(10): 1511-4. Epub 2016 Mar 9.

Bello L, Flanigan KM, Weiss RB; United Dystrophinopathy Project., Spitali P., Aartsma-Rus A.,

Muntoni F., Zaharieva I.,Ferlini A., Mercuri E., Tuffery-Giraud S., Claustres M., Straub V.,

Lochmuller H., Barp A., Vianello S., Pegoraro E., Punetha J., Gordish-Dressman H., Giri M.,

McDonald CM., Hoffman EP., Cooperative International Neuromuscular Research Group.,

Association Study of Exon Variants in the NF-kB and TGFβPathways Identifies CD40 as a Modifier

of Duchenne Muscular Dystrophy; Am J Hum Genet.2016 Nov.3;99(5): 1163-1171. Epub 2016 Oct

13

Elahi H., Bertorini TE “Juvenile Inflammatory Myopathy” Journal of Clinical Neuromuscular

Disorders. 2016 Sep;18(1):21-7.

Bello L., Morgenroth LP., Gordish-DressmanH., Hoffman EP., McDonald CM., Cirak S., CINRG

Investigators., DMD Genotypes and loss of ambulation in the CINRG Duchenne Natural History

Study; Neurology. 2016 Jul 26;87(4): 401-9. Epub 2016 Jun 24.

ALSUntangled No. 31: Protandim. Amyotrophic Lateral Sclerosis and Frontotemporal

Degeneration, 2016; 17: 154-156.

Punetha J, Kesari A, Uapinyoying P, Giri M, Clarke NF, Waddell LB, North K, Bönnemann CG,

Donkervoort S, Neu M, Plotz PH, Smith EC, Tesi-Rocha C, Bertorini TE, Tarnopolsky MA, Reitter

B and Hoffman EP. “Targeted re-sequencing Emulsion PCR panel for myopathies: Results in 94

cases. Journal of Clinical Neuromuscular Disorders. 2016 May 27;3(2):209-225.

Punetha, Jaya, Simin Mansoor, Tulio E. Bertorini, Akanchha Kesari, Kristy J. Brown, and Eric P.

Hoffman. "Somatic Mosaicism Due to a Reversion Variant Causing Hemi-atrophy: A Novel Variant

of Dystrophinopathy."Eur J Hum Genet European Journal of Human Genetics (2016): n. pag.

Bello, Luca, Akanchha Kesari, Heather Gordish-Dressman, Avital Cnaan, Lauren P. Morgenroth,

Jaya Punetha, Tina Duong, Erik K. Henricson, Elena Pegoraro, Craig M. Mcdonald, and Eric P.

Hoffman. "Genetic Modifiers of Ambulation in the Cooperative International Neuromuscular

06/08/2017 20

Research Group Duchenne Natural History Study." Annals of Neurology Ann Neurol. 77.4 (2015):

684-96.

Bertorini TE, Shen L. Disorders of the adrenal glands, the neurologist’s point of view in G. Santulli

ed, Adrenal Glands from Pathophysiology to Clinical Evidence, Nova Science Publishers New York.

2015.

Bertorini, Tulio E., and Aboubakar G. Sharaf. "An Overview of Laryngeal Muscle Single Fiber

Electromyography." Journal of Clinical Neurophysiology 32.4 (2015): 304-08.

Bello, L., H. Gordish-Dressman, L. P. Morgenroth, E. K. Henricson, T. Duong, E. P. Hoffman, A.

Cnaan, and C. M. Mcdonald. "Prednisone/prednisolone and Deflazacort Regimens in the CINRG

Duchenne Natural History Study." Neurology 85.12 (2015): 1048-055.

Macchi, Z, Wang Y, Moore D, Katz J, Saperstein D, Walk D, Simpson E, Genge A, Bertorini T, et

al. A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis and

frontotemporal degeneration: Possible mitochondrial biomarker target engagement. In press.

Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Vol. 16. No. 5-6 p. 345-352. 2015.

Bertorini T E, Sharaf A. Overview of Laryngeal Muscle Single Fiber Electromyography. Journal

of Clinical Neurophysiology. Journal of Clinical Neurophysiology 2015 Aug; 32 (4): 304-8

Ly H, Shah N, Bertorini T. An adult male with progressive spastic paraparesis and gait. Journal of

Clinical Neuromuscular Disease, 2014; 16: 98-103.

Bertorini TE, Perez A. Neurological Complications of Disorders of the Adrenal Glands. Handb Clin

Neurol. 2014; 120: 749-71.

ALSUntangled No. 26: Lunasin. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration,

2014;15:622-626.

ALSUntangled No. 25: Ursodiol. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration,

2014; 15:475-478.

Mansoor S, Bertorini TE. Peripheral neuropathy and monoclonal gammopathy. Journal of Clinical

Neuromuscular Disease. 2014.

CINRG Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of

cardiomyopathy in Duchenne muscular dystrophy. Spurney C1, Shimizu R, Hache LP, Kolski H,

Gordish-Dressman H, Clemens PR; the CINRG Investigators. Muscle Nerve. 2014 Jan 3. doi:

10.1002/mus.24163.

Bertorini TE, Perez A. Neurological Complications of Disorders of the Adrenal Glands, Handbook

of Neurology, Elssevier, in J. Biller Neurological Complications of Medical Disorders. 2014.

Malignant Hyperthermia in Katargi et al., Neuromuscular Disorders in Clinical Practice, Elsevier,

2014.

T. Bertorini in Katirgi G, et al. Clinical Neuromuscular Diseases. 2nd Edition. Elsevier, in press.

ALSUntangled No. 23: The Rife Machine and retroviruses. Amyotrophic Lateral Sclerosis and

Frontotemporal Degeneration, 2014; 15: 157-159.

Mansoor Simon, Bertorini Tulio E. A Man with Progressive Lower Extremity Weakness and

Monoclonal Gammopathy. J Clin Neuromusc Dis 2013; 14: 194-203.

ALSUntangled No. 22: Propofol. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration,

2013; 14: 640-642.

ALSUntangled No. 21: Fecal transplants. Amytorophic Lateral Sclerosis and Frontotemporal

Degeneration, 2013; 14: 482-485.

ALSUntangled No. 20: The Deanna Protocol. Amyotrophic Lateral Sclerosis and Frontotemporal

Degeneration, 2013; 14: 319-323.

ALSUntangled No. 19: Sodium chlorite. Amyotrophic Lateral Sclerosis and Frontotemporal

Degeneration, 2013;14: 236-238.

ALSUntangled No. 18: Apoaequorin (Prevagen). Amyotrophic Lateral Sclerosis and Frontotemporal

Degeneration, 2013; 14: 78-79.

The cooperative international neuromuscular research group Duchenne natural history study:

glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of

06/08/2017 21

disease progression as measured by manual muscle testing and other commonly used clinical trial

outcome measures. Henricson EK1, Abresch RT, Cnaan A, Hu F, Duong T, Arrieta A, Han J,

Escolar DM, Florence JM, Clemens PR, Hoffman EP, McDonald CM; CINRG Investigators.

Muscle Nerve. 2013 Jul; 48(1):55-67. doi: 10.1002/mus.23808.

The cooperative international neuromuscular research group Duchenne natural history study--a

longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods

used. McDonald CM1, Henricson EK, Abresch RT, Han JJ, Escolar DM, Florence JM, Duong T,

Arrieta A, Clemens PR, Hoffman EP, Cnaan A; Cinrg Investigators. Muscle Nerve. 2013 Jul;

48(1):32-54. doi: 10.1002/mus.23807.

Garcia-Rosell M, Moore S, Pattanaik D, Menon Y, Bertorini T, Carbone L. Signal recognition

antibody-positive myopathy and response to intravenous immunoglobulin G (IVIG). J Clin

Rheumatol 2013 June; 19(4): 214-217.

ALSUntangled No. 17: “When ALS Is Lyme”. Amyotrophic Lateral Sclerosis, 2012; 13:487-491.

ALSUntangled No. 16: Cannabis. Amyotrophic Lateral Sclerosis, 2012;13:400-404.

ALSUntangled No. 15: Coconut Oil. Amyotrophic Lateral Sclerosis, 2012;13:328-330.

ALSUntangled No. 14: Mototab. Amyotrophic Lateral Sclerosis, 2012; 13:161-164.

Hubbert C, Pendley C, Mansoor S, Bertorini TE. Myotonic Dystrophy Type 2 with Electrical

Myotonia and without Weakness. AANEM. Online Case CME, AANEM Website, January 2013.

Escolar DM, Hache LP, Clemens, PR, Cnaan A, McDonald CM, Viswanathan V, Kornberg AS,

Escolar DM, Zimmerman A, Bertorini T, et al. Pentoxifyline rescue treatment in DMD. A

randomized double blind clinical trial. Neurology 28 (22) 904-913, 2012.

Chai Y, Bertorini TE, Khan RB, Randall MB, Shadle MK. Dermatomyositis Presenting with Focal

Scleroderma-like Skin Changes. J. Clin Neuromusc Dis. 2012, June 13;(4) 191-195.

Escolar D, Henricson E, Bartczak M, Parker K. et al., CINRG pilot trial of coenzyme Q10 in steroid-

treated Duchenne muscular dystrophy. Muscle Nerve, 2011, Aug: 44 (2): 174-178.

Chai Y, Bertorini TE, Li YD, Mitchell C, Guan H. Limb edema and anasarca with severe

dermatomyositis: Report of four cases. Journal of Clinical Neuromuscular Dis. 2011; 21:439-443.

CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy. Spurney CF1,

Rocha CT, Henricson E, Florence J, Mayhew J, Gorni K, Pasquali L, Pestronk A, Martin GR, Hu F,

Nie L, Connolly AM, Escolar DM; Cooperative International Neuromuscular Research Group

Investigators. Muscle Nerve. 2011 Aug;44(2):174-8. doi: 10.1002/mus.22047.

Bertorini, TE, et al (CINRG group). Randomized, blinded trial of weekend versus daily prednisone

in Duchenne muscular dystrophy. Neurology, 2012, Aug 2; 77(5): 444-52 Epub 2011 Jul 13.

Escolar DM, Hache LP, Clemens, PR, Cnaan A, McDonald CM, Viswanathan V, Kornberg AS,

Bertorini, TE, eTal (CINRG Group). Randomized, blinded trial of weekend versus daily

prednisone in Duchenne Muscular Dystrophy. Neurology, 2012, Aug2; 77(5): 444-52 Epub 2011 Jul

13.

SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy. Pegoraro E1,

Hoffman EP, Piva L, Gavassini BF, Cagnin S, Ermani M, Bello L, Soraru G, Pacchioni B,

Bonifati MD, Lanfranchi G, Angelini C, Kesari A, Lee I, Gordish-Dressman H, Devaney JM,

McDonald CM;

Cooperative International Neuromuscular Research Group. Neurology. 2011 Jan 18; 76(3):219-26.

doi: 10.1212/WNL.0b013e318207afeb.

Bertorini TE. (ed) Neuromuscular Disorders: Treatment and Management. Elsevier, Boston, 2011.

Author and Contributing Author for: Introduction; Chapter 7 - Immunotherapy in Neuromuscular

Disorders; Chapter 10 - Perioperative Care in Neuromuscular Disorders; and, Chapter 20 -

Management and Treatment of Acquired Metabolic Endocrine and Nutritional Neuropathies/

Myopathies.

Mitchell CW. Bertorini TE. Chapter 7- Principles and Guidelines of Immunotherapy in

Neuromuscular Disorders. Neuromuscular Disorders: Treatment and Management. Saunders

Elsevier, 2011.

06/08/2017 22

Bertorini TE, Li, YD, Bassam BA, Mitchell, CW. Chapter 10-Perioperative Management of

Patients with Neuromuscular Disorders. Neuromuscular Disorders: Treatment and Management.

Saunders Elsevier, 2011.

Bassam, BA, Bertorini TE. Chapter 20 – Neuromuscular Manifestations of Acquired Metabolic,

Endocrine, and Nutritional Disorders. Neuromuscular Disorders: Treatment and Management.

Saunders Elsevier, 2011.

Pegoraro E, Hoffman EP, Piva L, Gavassini BF, et al., SPP1 genotype is a determinant of disease

severity in Duchenne muscular dystrophy. Neurology. 2011, Jan 18; 76(3): 219-226.

ALSUntangled No. 13: Bee Venom, Amyotrophic Lateral Sclerosis, 2011;12:471-472.

ALSUntangled No. 12: Dean Kraft, Energy Healer. Amyotrophic Lateral Sclerosis, 2011;12:389-391.

ALSUntangled No. 11: Nu Tech Mediworld. Amyotrophic Lateral Sclerosis, 2011;12:309-311.

Pegoraro E, Hoffman EP, Piva L, Gavassini BF, et al., Bertorini TE, CINRG Investigators. SPPI

genotype is a determinant of disease severity in Duchenne muscular dystrophy. Neurology 2011; 76,

219-226.

Bertorini TE, Rashed H, Zeno M, Tolley EA, Igarashi M, Li YD. Effects of 3-4 Diaminopyridine

(DAP) in Motor Neuron Diseases. J Clin Neuromuc Dis 2011; 12:129-137.

Escolar Diana, Hache Lauren, Clemens, Paul, Cnaan Avital, McDonald Craig, Viswanathan

Venkataraman, Kornberg Andrew, Bertorini, Tulio, et al. (CINRG group) Randomized, blinded trial

of weekend versus daily prednisone in Duchenne muscular dystrophy. Neurology. 2011; Aug

2;77(5) 444-452. Nishant Dwivedi, Marco Radic, Jerry Thompson, Christie Michael, D. Betty Lew,

Sandra Arnold, periorbital edema. In Press.

Masanori Igarashi, Tulio Bertorini, Linda K. Myers, Monica L. Brown. A case of bilateral Chai,

Yaohui, Bertorini, Tulio, McGrew Frank. Hereditary Inclusion Body Myopathy Associated with

Cardiomyopathy: Report of Two Siblings. Muscle & Nerve, Vol 43, No 1, January 2011, pp 133-

136.

M Pasnoor, MD, G Wolfe, MD, S Nations, MD, J Trivedi, MD, R Barohn, MD, L Herbelin, BS, A

McVey, MD, M Dimachkie, MD, J Kissel, MD, R Walsh, MD, A Amato, MD, T Mozaffar, MD, M

Hungs, MD, L Chui, MD J. Goldstein, MD, S Novella, MD, T Burns, MD, L Phillips, G Claussen,

MD, A Young, MD, T Bertorini, MD, S Oh, MD. Clinical Findings in MuSK-Antibody Positive

Myasthenia Gravis: A U.S. Experience. Muscle & Nerve, March 2010;41(3):370-374.

Chai, Yaohui and Bertorini, Tulio. A Female with Progressive Four-Limb Paresthesias and Gait

Difficulty. A Case Review. J Clin Neuromusc Dis 2010; 11:191-197.

O’Carroll, Peter and Bertorini, Tulio. Transient Neonatal Myasthenia Gravis in a Baby Born to a

Mother with New-Onset Anti-MuSK-Mediated Myasthenia Gravis. J Clin Neuromusc Dis Dec

2009; 11:69-71.

O’Carroll Peter, Bertorini Tulio, Maccarino Sue. Artifact on Electromyography Produced by an

Implanted Sacral Nerve Stimulator. J Clin Neuromusc Dis Dec 2009,11:77-78.

Davonna S. Ledet, MS, Rupert Handgretinger, MD, Tulio E. Bertorini, MD, Gregory A. Hale, Raul

C. Ribeiro, MD and Raja B. Khan, MD. Leucoencephalopathy, Transverse Myelopathy, and

Peripheral Neuropathy in Association with Glutamic Acid Decarboxylase-65 Antibodies in Children

with Cancer. Journal of Child Neurology November 2008; 23; 11: 1357 originally published online

May 12, 2008.

Bertorini TE, Perez A. Tammaa, M. Disorders of the adrenal glands and new corticosteroid

treatment. Chapter 79 of Interface of Neurology and Internal Medicine. J Biller (ed). Elsevier,

Boston 2008.

Bertorini TE. 101 Neuromuscular Case Studies. Bertorini TE (ed). Elsevier, Boston, 2008.

Mayhew JE, Florence JM, Mayhew TP, Henricson EK, et al. and Bertorini TE (participating

CINRG investigator). Reliable surrogate outcome measures in multicenter clinical trials of Duchenne

muscular dystrophy. Muscle Nerve. 35:36-42. 2007.

Holt AE, Mitchell CW, Maccarino S, Bertorini TE. An Older Female with Chronic Fluctuating

Weakness. J Clin Neuromusc Dis Mar 2007; 8:152-160.

06/08/2017 23

Al-Hayk EA, Bertorini TE. Neuromuscular Complications in Uremics: A review. The Neurologist

2007;13: 131-137.

Dunckley T, Huentelman MJ, Craig DW, Pearson JV, Szelinger S, Joshipura K, Halperin RF,

Stamper C, Jenson KR, Letizia D, Hesterlee SE, Pestronk A, Levine T, Bertorini T, et al. Whole-

Genome Analysis of Sporadic Amyotrophic Lateral Sclerosis. N Engl J Med. 2007;357: 775-788.

Mitchell CW, Bertorini TE. Diffusely Increased Insertional Activity: “EMG Disease” or

Asymptomatic Myotonia Congenita? Arch Phys Med Rehabil 2007 Sep;89(9):1212-1213.

Buyse GM, Goemans N, Henricson EK, Jara A, van den Hauwe M, Leshner R, Florence JM,

Mayhew JE, Escolar DM. CINRG Pilot Trial of Oxatomide in Steroid-Naïve Duchenne Muscular

Dystrophy. European Journal of Paediartric Neurology, 2007, Vol 11, Issue 6, pages 337-340.

Mayhew JE, Florence JM, Mayhew TP, Henricson EK, Leshner RT, McCarter RJ, Escolar DM.

Reliable Surrogate Outcome Measures in Multicenter Clinical Trials of Duchenne Muscular

Dystrophy, Muscle and Nerve, 2007, Vol 35, Issue 1, pages 36-42.

Buyse GM, Goemans N, Henricson EK, Jara A, van den Hauwe M, Leshner R, Florence JM,

Mayehw JE, Escolar DM. CINRG Pilot Trial of Oxatomide in Steroid-Naïve Duchenne Muscular

Dystrophy, European Journal of Pediatric Neurology, 2007, Vol 11, Issue 6, pages 337-340.

Mayhew JE, Florence JM, Mayhew TP, Henricson EK, Leshner RT, McCarter RJ, Escolar DM.

Reliable Surrogate Outcome Measures in Multicenter Clinical Trials of Duchenne Muscular

Dystrophy, Muscle and Nerve, 2007, Vol 35, Issue 1, pages 36-42.

Bertorini TE. Chapter: Peripheral Sensory Conduction Studies, in Clinical Neurophysiology of

Peripheral Nerve Diseases, Volume of Clinical Neurophysiology Handbook. Daulbe J and Mauguire

F (eds). Elsevier. 2006.

Mitchell C, Bertorini TE. A boy with proximal weakness and cardiomyopathy. Journal of Clinical

Neuromuscular Disease. 8(2):83-91, December 2006.

Perez A, Bertorini TE. A woman with spontaneous focal muscle movements. Journal of Clinical

Neuromuscular Disease. 8(1):35-44, September 2006.

Gupta D, Bertorini TE. Troponin levels in patients with myopathies. Journal of Clinical

Neuromuscular Disease. 7(4):212, June 2006.

Escolar DM, Buyse G, Henricson E, Leshner R, et al., CINRG investigators. CINRG randomized

controlled trial of creatine and glutamine in Duchenne muscular dystrophy. Ann Neurol 2005, Jul;58

(1): 151-5.

Escolar DM, Buyse G, Henricson E, Leshner R, Florence J, Mayhew J, Tesi-Rocha C, Gorni K,

Pasquali L, Patel KM, McCarter R, Huang J, Mayhew T, Bertorini T, Carlo J, Connolly A, Clemens

P, Goemans N, Iannaccone S, Igarashi M, Nevo Y, Pestronk A, Subramony SH, Vedanarayanan VV,

Wessel H, and the CINRG group.

Randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy. Annals

Neurol. Jul: 58 (1): 151-155, 2005.

Owens WE, Gupta D, Bertorini TE, Enhancement of contralateral ptosis upon passively holding an

eyelid in mitochondrial myopathy resembling myasthenia gravis. Journal of Clinical Neuromuscular

Disease. 6(4):188-190, 2005.

Owens WE, Bertorini TE, Holt H T, Shadle HT. Diffuse fasciitis with eosinophilia (Shulman

Syndrome). Images in Neuromuscular disease. J. Clin Neuromusc Dis 6:99-101, 2004.

Bertorini T, Narayanaswami P, Rashed H. Charcot-Marie-Tooth disease (hereditary motor sensory

neuropathies) and hereditary sensory and autonomic neuropathies. Neurologist. 2004 Nov;10(6):327-

37.

Martinez P, Bertorini TE. La neuropatia diabetica. Revista Neurologica Argentina, 29:72-84, 2004.

Gupta Devanchi, Bertorini TE. Clinical Approach to a Patient Presenting with Foot Drop.

Neuromuscular Case Review. J Clin Neuromusc Dis 5(3):154-165. March 2004.

Bertorini TE. Preoperative management of patients with neuromuscular disorders. Neurology

Clinics of North America. Saunders. May 2004. Vol 22, No. 2; 293-313.

06/08/2017 24

Bertorini TE. Perisurgical management of patients with neuromuscular disorders. Perioperative

Management and Preoperative assessment of neurologic diseases. Néstor Gálvez-Jiménez (ed.),

Neurologic Clinics of North America, Elsevier Saunders, Volume 22 (2): pp. 293-313, 2004.

LeDoux MS, Gupta D, Bertorini TE. Dropped head presentation of mitochondrial myopathy.

Journal of Clinical Neuromuscular Diseases Vol 4, No 2, Dec. 2003; 108-114.

Bertorini T, Narayanaswami P. Autoimmune Neuropathies. Comprehensive Therapy 2003; 29 (4):

194-209.

Ahmed SN, Bertorini T, Narayanaswami P, Senthilkumar K. Clinical Approach to a Patient

Presenting with Muscle Stiffness. Journal of Clinical Neuromuscular Disease. Vol 4, No 3, March

2003, 150-160.

Bertorini T. Lumbosacral Plexopathy Causes Intrapartum Foot Drop. Journal Watch Neurology.

January 2003.

Eisenberg I, Grabov-Nardini G, Nochner H, Korner M, Sadeh M, Bertorini T, Bushby K, Castellan

C, Felice K, Mendell J, Merlini M, Shilling C, Wirguin I, Argov Z, Mitrani-Rosenbaum S. Mutations

spectrum of the GNE gene in Hereditary Inclusion Body Myopathy sparing the quadriceps. Human

Mutation Jan;21(1):99, 2003. Neurology 2002.

Weintraub MI, Wolfe GI, Barohn RA. Et al: Static magnetic field therapy for symptomatic diabetic

neuropathy: A randomized, double-blind, placebo-controlled trial. Arch Phys Med Rehab 2003; 84:

736-46.

Escolar DM, Henricson EK, Pasquali L, Gorni K, Hoffman, EP. And the CINRG investigators.

Collaborative Translational Research Leading to Multicenter Clinical Trials in Duchenne Muscular

Dystrophy: The Cooperative International Neuromuscular Research Group (CINRG).

Neuromuscular Disorders, 2002, Vol 12, pages S-147-S154

Bertorini TE. Malignant Hyperthermia. In: Neuromuscular Disorders in Clinical Practice, Kitirgi,

Preston, Kaminski HJ (ed.), Butterworth-Heinemann, 2002, pp. 1021-1027.

Bertorini TE. (Editor) Clinical Evaluation and Diagnostic Tests for Neuromuscular Disorders.

Butterworth-Heinemann, Amsterdam, 2002. Also, the author of the following chapters:

Chapter 1: Bertorini TE, Overview of Classification of Neuromuscular Disorders, pp. 1-14.

Chapter 2: Bertorini T, Clinical Evaluation and Clinical Laboratory Tests, pp. 15-98.

Chapter 19: Bertorini TE, Horner LH, Histology and Histochemistry of Muscle and Nerve, 595-692.

Appendixes 1: Bertorini TE, Narayanaswami P., Senthilkumar k., Diagnostic Pathways of

Generalized Neuromuscular Disorders and Diagnostic Workup of Segmental or Focal Disorders, pp

739-762.

Appendixes 2: Bertorini TE, Narayanaswami P., Senthilkumar k., Important Neuromuscular

Disorder Diagnostic Criteria, pp. 763-798.

Appendixes 3: Bertorini TE, Narayanaswami P., Senthilkumar k., Protocols of Evaluation and

Neuromuscular Disorder Rating Scales, pp. 799-826.

Appendixes 4: Bertorini TE, Narayanaswami P., Senthilkumar k., Important Neuromuscular Web

sites, pp. 827-836.

Escolar DM, Henricson EK, Pasquali L, Gorni K, Hoffman EP. Collaborative translational research

leading to multicenter clinical trials in Duchenne muscular dystrophy: The Cooperative International

Neuromuscular Research Group (CINRG). Neuromuscul Disord. 2002 Oct;12 Suppl 1: S147-154.

Escolar DM, Henricson EK, Mayhew J, Florence J, Leshner R, Patel KM, Clemens PR and the

CINRG investigators. Clinical Evaluator Reliability for Quantitative and Manual Muscle Testing

measures of Strength in Children. Muscle & Nerve, 2001, Vol 24, Issue 6, pages 787-793.

Garcia-Roseell M, Moore, S. Patanaik D, Menon, Y, Bertorini T, Carbone L. Signal recognition

antibody positive myopathy and response to immunoglobulin. Journal of Clinical Rheumatology. In

press.

Bertorini TE, Sebes JI, Palmieri GMA, Igarashi M, Horner LH. Diltiazem in the treatment of

calcinosis in juvenile dermatomyositis. Journal of Clinical Neuromuscular Disease 2(4):191-193,

2001.

06/08/2017 25

Escolar DM, Henricson EK, Mayhew J, Florence J, Leshner R, Patel KM, Clemens PR, and the

CINRG Investigators. Clinical evaluator reliability for quantitative and manual muscle testing

measures of strength in children. Muscle & Nerve 24:787-793, 2001.

Multicenter Trial. Escolar DM, Henricson EK, Bertorini T, et al. Clinical evaluator reliability for

quantitative and manual muscle testing measures of strength in children. Muscle & Nerve 2001.

June; 24 (6) 787-93.

Book Chapters: Bertorini, TE, Muscular Dystrophies. In: Neuromuscular Disorders: Expert

Clinician’s View, R Pourmand (ed.), Butterworth-Heinemann, 2001.

Narayanaswami P, Bertorini TE. Progressive amyotrophy as a late complication of myelopathy. J

Neurol Sci 184(1):11-13, 2001.

Khan RB, Bertorini TE, Levin MC. HTLV-1 and its neurological complications. The Neurologist

7:271-278, 2001.

Wulff EA, Bertorini TE. Parkinson Disease: New forms of diagnosis and treatment. Medico

Interamericano 19(7):268, 2000.

Wulff EA, Bertorini TE. Neurologic complications of systemic inflammatory and autoimmune

diseases. Medico Interamericano 19(7):111, 2000.

Narayanaswami P, Bertorini TE, Halford H. Selective paraspinal amyotrophy. J Neurol Sci

176(1):70-74, 2000.

Bedlack RS, Bertorini TE, Sanders DB. Hidden afterdischarges in slow channel congenital

myasthenic syndrome. J Clin Neuromusc Dis 1:186-189, 2000.

Apfel SC, Schwartz S, Adornato BT, Freeman R, Biton V, Randell M, Vinik A, Giuliani M, Stevens

JC, Barbano R, Dyck PJ and the rhNGF Clinical Investigator Group. Efficacy and safety of

recombinant human nerve growth factor in patients with diabetic polyneuropathy. A randomized

controlled trial. JAMA 284(17):2215-2221, 2000.

Narayanaswami P, Bertorini TE, Pourmand R, Horner L. Long-term tracheotomy ventilation in

neuromuscular diseases: patient acceptance and quality of life. Neurorehabilitation & Neural

Repair 14:135-139, 2000.

Narayanaswami P, Bertorini TE. The dropped head syndrome. J Clin Neuromusc Dis 2(2):106-

112, 2000.

Halford H, Graves A, Bertorini T. Muscle and nerve imaging techniques in neuromuscular diseases.

J Clin Neuromusc Dis 2:41-51, 2000.

Schweizer V, Woodson GE, Bertorini TE. Single-fiber electromyography of the laryngeal muscles.

Muscle & Nerve 22(1):111-114, 1999.

Alzagatiti BI, Bertorini TE, Horner LH, Maccarino VS, O’Brien T. Focal Myositis Presenting with

Radial Nerve Palsy. Muscle & Nerve 22:956-959, 1999.

Varelas PN, Bertorini TE, Halford H. Bilateral ophthalmoplegia and exophthalmos complicating

central hemodialysis catheter placement. Am J Kidney Dis 33(5):966-969, 1999.

Siddiqui MF, Bertorini TE. Hypophosphatemia-induced neuropathy: Clinical and

electrophysiologic findings. Muscle Nerve 21:650-652, 1998.

Nymann T, Hathaway DK, Bertorini TE, Shokouh-Amiri MH, Gaber AO (DCCT Research Group).

Studies of the Impact of Pancreas-Kidney and Kidney Transplantation on Peripheral Nerve

Conduction in Diabetic Patients. Transplantation Proceedings 30:323-324, 1998.

Almsaddi M, Bertorini TE, Seltzer WK. Demyelinating Neuropathy in a Patient with Multiple

Sclerosis and Genotypical HMSN-1. Neuromuscular Disorders 8(2):87-89, 1998.

Pegoraro E, Marks H, Garcia CA, Crawford T, Mancias P, Connolly AM, Fanin M, Martinello F,

Trevisan CP, Angelini C, Stella A, Scavina M, Munk RL, Servidei S, Bonnemann CC, Bertorini T,

Acsadi G, Thompson CE, Gagnon D, Hoganson G, Carver V, Zimmerman RA, Hoffman EP.

Laminin alpha2 Congenital muscular dystrophy: genotype/phenotype studies of 22 patients.

Neurology 51(1):101-110, 1998.

Bertorini TE. Inflammatory Myopathies (Polymyositis, Dermatomyositis, Inclusion Body

Myositis). Comp Ther 24:494-502, 1998.

06/08/2017 26

Bertorini TE. Myoglobinuria, Malignant Hyperthermia, Neuroleptic Malignant Syndrome,

Serotonin Syndrome - In - Neurology Clinics of North America, Sanders Publishing Company, Vol.

15(3), pp. 649-671, 1997.

Elsehety A, Bertorini TE. Neurological and Neuropsychiatric Complications of Crohn's Disease.

Southern Medical Journal 90(6):606-610, 1997.

Khan AR, Bertorini TE, Horner LH. Tongue Involvement in a Patient with Granulomatous

Myositis. South Med J 90(9):937-939, 1997.

Jaster JH, Dohan FC Jr, Bertorini TE, Bass JE, Mönkemüller KE, Handorf CR, Gerald BE. Solitary

spinal cord sarcoidosis without other manifestations of systemic sarcoidosis. Clin Imaging 21(1):17-

22, 1997.

Almsaddi M, Bertorini TE, Bastnagel W. Remission of Myasthenia Gravis Caused by Proteinuria

in Nephrotic Syndrome. Muscle Nerve 20:1583-1586, 1997.

Varelas PN, Bertorini TE, Kapaki E, Papageorgiou CT. Paget’s disease of bone and motor neuron

disease. Muscle Nerve. 1997 May;20(5):630.

Bertorini TE, Gelfand MS, O'Brien TF. Encephalopathy Due to Capillary Leak Syndrome.

Southern Med J 90(10):1060-1062, 1997.

Bertorini TE. Myoglobinuria, malignant hyperthermia, neuroleptic syndrome and serotonin

syndrome. Neurol Clin 15(3):649-671, 1997.

The National Institute of Neurological Disorders and Stroke (NINDS) tPA Stroke Study Group. A

Systems Approach to Immediate Evaluation and Management of Hyperacute Stroke. Experience at

eight centers and implications for community practice and patient care. Stroke 28:1530-1540, 1997.

Bertorini TE, Siegel IM. Bent spine syndrome. J Neurol Neurosurg Psychiatry. 1997

Apr;62(4):429.

Jaster JH, Bertorini TE, Swims MP, Dohan FC Jr, Menke PG, Becske T, Monkemuller KE.

Dropped head syndrome. Neurology. 1997 Feb; 48(2):551; author reply 551-2.

Jaster JH, Bertorini TE, Dohan FC, Jr., O'Brien TF, Wang H, Becske T, Menke PG, Handorf CR,

Horner LH, Mönkemüller KE. Solitary focal demyelination in the brain as a paraneoplastic disorder.

Med Pediatr Oncol 26(2):111-115, 1996.

Bertorini TE, Nance A, Horner LH, Greene W, Gelfand MS, Jaster JH. Complications of

intravenous gammaglobulin in neuromuscular and other diseases. Muscle Nerve 19(3):388-391,

1996.

Palmieri GMA, Bertorini TE, Griffin JW, Igarashi M, Karas JG. Assessment of whole body

composition with dual energy x-ray absorptiometry in Duchenne muscular dystrophy: Correlation of

lean body mass with muscle function. Muscle Nerve 19(6):777-779, 1996.

DCCT Research Group. Effects of intensive diabetes therapy on neuropsychological function in

adults in the diabetes control and complications trial. Ann Intern Med 124:379-388, 1996.

Santorelli FM, Sciacco M, Tanji K, Shanske S, Vu TH, Golzi V, Griggs RC, Mendell JR, Hays AP,

Bertorini TE, Pestronk A, Bonilla E, DiMauro S. Multiple mitochondrial DNA deletions in

sporadic Inclusion Body Myositis: A study of 56 patients. Ann Neurol 39(6):789-795, 1996.

Jaster JH, Dohan FC Jr, Bertorini TE, Menke PG, Swims MP. Choroid plexus histoplasmoma:

clinical, pathologic, and imaging findings. South Med J 89(9):902-905, 1996.

Jaster JH, Bertorini TE, Swims MP, Dohan FC Jr, Menke PG, Becske T, Mönkemüller KE.

Cervical kyphosis after resolution of myopathic head drop: a case report. Spine 21:2023-2025, 1996.

Jaster JH, Porterfield LM, Bertorini TE, Dohan FC Jr, Becske T. Stroke and cardiac arrest.

Neurology 1996 Nov; 47(5):1357.

Santorelli FM, Sciacco M, Tanji K, Shanske S. Vu THE, Golzi V, Griggs RC, Mendell JR, Hays AP,

Bertorini TE, Pestronk A, Bonilla, DiMauro S. Multiple mitochondrial DNA deletions in sporadic

inclusion body myositis. Study of 56 patients. Ann Neurol. 1996 June;39(6):789-95.

Bertorini T, Halford H, Lawrence J, Vo D, Wassef M. Contrast-enhanced magnetic resonance

imaging of the lumbosacral roots in the dysimmune inflammatory polyneuropathies. J

Neuroimaging (US) 5(1):9-15, 1995.

06/08/2017 27

Nutting DF, Schriock EA, Palmieri GM, Bittle JB, Elmendorf BJ, Horner LH, Edwards MC, Griffin

JW, Sacks HS, Bertorini TE. Octreotide enhances positive calcium balance in Duchenne muscular

dystrophy. Am J Med Sci 310(3):91-98, 1995.

DCCT Research Group. Effect of intensive diabetes treatment on nerve conduction in the diabetes

control and complications trial, Ann Neurol 38:869-880, 1995.

Bertorini TE, Laster R. False evidence of carotid stenosis on magnetic resonance angiography

caused by surgical clips. J Neuroimaging 5(4):206-208, 1995.

Jaster JH, Porterfield LM, Bertorini TE, Dohan FC, Jr., Becske T. Cardiac arrest following

vertebrobasilar stroke. J Tenn Med Assoc 88(8):309, 1995.

DCCT Research Group. The diabetes control and complications trial (DCCT). The effect of

intensive diabetes therapy on the development and progression of neuropathy. Ann Int Med

122(8):561-568, 1995.

Meyer M, Gaines K, Payne A, Bales C, Malcolm J, Barlow R, Wilson M, Cape C, Bertorini T,

Misulis K, Paulsen W, Shepard D, et al. The National Institute of Neurological Disorders and Stroke

rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. NEJM

333(24):1581-1587, 1995.

Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for

asymptomatic carotid artery stenosis. JAMA 273:1421-1428, 1995.

The Asymptomatic Carotid Atherosclerosis Study Group. Carotid endarterectomy for patients with

asymptomatic internal carotid artery stenosis. National Institute of Neurological Disorders and

Stroke, National Institutes of Health, Department of Health and Human Services, Bethesda, MD,

USA. J Neurol Sci 129:76-77, 1995.

The Asymptomatic Carotid Atherosclerosis Study Group. Endarterectomy for asymptomatic carotid

artery stenosis. National Institute of Neurological Disorders and Stroke, National Institutes of

Health, Department of Health and Human Services, Bethesda, MD, USA. JAMA 273:1421-2428,

1995.

Bertorini TE, Woodhouse C, Horner L. Muscle hypertrophy secondary to the tethered cord

syndrome. Muscle & Nerve 17:331-335, 1994.

Bertorini TE, Stalberg E, Yuson CP, Engel WK. Single-fiber electromyography in neuromuscular

disorders: correlation of muscle histochemistry, single-fiber electromyography, and clinical findings.

Muscle & Nerve 17:345-353, 1994.

Griffin JW, Tooms RE, Vander Zwaag R, O'Toole ML, Bertorini TE. Eccentric and concentric

muscle performance in patients with spastic paresis secondary to motor neuron disease. A

preliminary report. Neuromuscl Disord 4(2):131-138, 1994.

Parham DM, Dias P, Bertorini T, von Wronski MA, Horner L, Houghton P. Immunohistochemical

analysis of the distribution of MyoD1 in muscle biopsies of primary myopathies and neurogenic

atrophy. Acta Neuropathol (Berl) 87(6):605-611, 1994.

Hirano M, Silvestri G, Blake EM, Lombes A, Minetti C, Bonilla E, Hays AP, Lovelace RE, Butler I,

Bertorini TE, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical,

biochemical and genetic features of an autosomal recessive mitochondrial disorder. Neurology

44(4):721-727, 1994.

The DCCT Research Group. Effect of intensive diabetes treatment on the development and

progression of long-term complications in Adolescents with insulin-dependent diabetes mellitus:

Diabetes control and complications trial. J Pediatr 125:177-188, 1994.

Moufarrej NA, Bertorini TE. Respiratory insufficiency in adult acid maltase deficiency. South

Med J 86(5):560-567, 1993.

Griffin JW, Tooms RE, Vander Zwaag R, Bertorini TE, O'Toole ML. Eccentric muscle

performance of elbow and knee muscle groups in untrained men and women. Med Sci Sports and

Exerc 25:936-944, 1993.

06/08/2017 28

DCCT Research Group. The diabetes control and complications trial (DCCT). The effect of

intensive treatment of diabetes on the development and progression of long-term complications in

insulin-dependent diabetes mellitus. NEJM 329:977-986, 1993.

Dick M, Bertorini TE, Igarashi M. Congenital muscular dystrophy presenting with respiratory

failure. Developmental Medicine and Child Neurology 34:264-282, 1992.

Bertorini TE, Palmieri GM, Griffin JW, Igarashi M, Hinton A, Karas JG. Effect of dantrolene in

Duchenne muscular dystrophy. Muscle & Nerve 14:503-507, 1991.

Puniani, TS, Bertorini TE. Tocainide therapy in muscle cramps and spasms due to neuromuscular

disease. Muscle Nerve 14:280-285, 1991.

Silva AB, Bertorini TE, Lemmi H. Polysomnography in idiopathic muscle pain syndrome. Arq

Neuro-Psiquiat (São Paulo) 49(4):437-441, 1991.

Cox LK, Bertorini T, Laster RE, Jr. Headaches due to spontaneous internal carotid artery

dissection: Magnetic Resonance Imaging evaluation and follow up. Headache 31(1):12-16, 1991.

Lichstein KL, Fischer SM, Eakin TL, Amberson JI, Bertorini T, Hoon PW. Psychophysiological

parameters of migraine and muscle-contraction headaches. Headache 31(1):27-34, 1991.

Bertorini TE, Gelfand M. Neurological complications of bacterial endocarditis. Comprehensive

Therapy 16(12):47-55, 1990.

Law PK, Bertorini TE, Goodwin TG, Chen M, Fang QW, Li HJ, Kirby DS, Florendo JA, Herrod

HG, Golden GS. Dystrophin production induced by myoblast transfer therapy in Duchenne muscular

dystrophy. Lancet. 1990, Jul 14;336(8707):114-5.

Woodall WC, III, Bertorini TE, Bakhtian B, Gelfand M. Spinal arachnoiditis with cryptococcus

neoformans in a non-immunocompromised child. Pediatric Neurology 6:206-208, 1990.

Bertorini TE, Thompson BF, Laster RE, Jr. MRI imaging in subacute bacterial endocarditis.

Archives of Internal Medicine 149:815-817, 1989.

Gelfand MS, Holladay R, Bertorini T, Adams RF. Staphylococcal pyomyositis with idiopathic

dermatomyositis. J Tenn Med Assoc. 1989 May; 82(5):243-4.

Bertorini TE, Laster RE Jr. Thompson BF, Gelfand M. Magnetic resonance imaging of the brain in

bacterial endocarditis. Arch Intern Med. 1989 Apr; 149(4):815-7.

Bertorini TE, Palmieri GM, Griffin JW. Effects of chronic treatment of diltiazem in Duchenne

muscular dystrophy. Neurology 38:609-613, 1988.

DCCT Research Group. Are continuing studies of metabolic control and microvascular

complications in insulin-dependent diabetes mellitus justified? N Engl J Med 318:246-50, 1988.

Knubley WA, Bertorini TE. Congenital muscular dystrophy with cerebellar atrophy: A case report.

Developmental Medicine and Child Neurology 30(3):378-83, 1988.

Bertorini TE. EMG in Polymyositis and Dermatomyositis - In - Polymyositis and Dermatomyositis,

MC Dalakas (ed.), Butterworth Publishers, Woburn, MA, 1988.

Bertorini TE. Histopathology of the Inflammatory Myopathies - In - Polymyositis and

Dermatomyositis, MC Dalakas (ed.), Butterworth Publishers, Woburn, MA, 1988.

Bertorini TE. Neuromuscular Diseases - In - Synopsis of Pediatrics, 7th Edition, RL Summitt (ed.),

Mosby Company, 1988.

Palmieri GM, Nutting DF, Bertorini TE. Smooth-muscle involvement in Duchenne muscular

dystrophy. N Engl, J Med. 1988 Nov 24;319(21):1418-9.

Bertorini TE. Idiopathic inflammatory neuropathies. Memphis Neuroscience Center Quarterly Vol

3(2), Summer, 1988.

Metcalf JC, Jr., Wood JB, Bertorini TE. Benign focal amyotrophy. Metrizamide CT evidence of

cord atrophy. Case Report. Muscle Nerve 3:338-45, 1987.

Bertorini TE. Histologic Studies in Muscle of Hyperparathyroidism - In - New Actions of

Parathyroid Hormone, SG Massry (ed.), Plenum Publishing Corporation, NY, 1987.

DCCT Research Group. Effects of age, duration and treatment of insulin-dependent diabetes

mellitus on residual ß-cell function: observations during eligibility testing for the Diabetes Control

and Complications Trial (DCCT). J Clin Endocrinol Metab 65:30-6, 1987.

06/08/2017 29

DCCT Research Group. Diabetes Control and Complications Trial (DCCT). Results of the

feasibility study. Diabetes Care 10:1-9: Jan-Feb 1987.

DCCT Research Group. Color photography vs. fluorescein angiography in the detection of diabetic

retinopathy in the Diabetes Control and Complications Trial (DCCT). Arch Ophthalmol 105:144,

1987.

Palmieri GM, Bertorini TE, Nutting DF. Calcium and blood pressure. Lancet. 1986 Nov

8,2(8515):1106.

DCCT Research Group. The diabetes control and complications trial (DCCT). Design and

methodological considerations for the feasibility phase. Diabetes 35:530-45, 1986.

Hazard PB, Bertorini TE, Griffin JP. Myasthenia gravis associated with small cell carcinoma of the

lung. J Tennessee Med Assoc 79(5):273-6, 1986.

Fox IH, Shefner R, Palmieri GM, Bertorini T. Duchenne muscular dystrophy: normal ATP

turnover in cultured cells. Adv Exp Med Biol 195:493-9, 1986.

da Cunha C, Bertorini TE, Lawrence J, Witherington JM. Central pontine myelinolysis - a

preventable condition. Two case reports and review of the literature. J Tenn Med Assoc 79:469-72,

1986.

Asa DK, Bertorini TE, Pinals RS. Case Report: Myositis ossificans circumscripta: A complication

of tetanus. Am J Med Sci 292(1):40-3, 1986.

Bertorini TE, Adornato BT, Kucera J. Benign focal amyotrophy. Arch Neurol. 1986 May;

43(5):432.

Griffin JW, McClure MH, Bertorini TE. Sequential isokinetic and manual muscle testing in

patients with neuromuscular disease. A pilot study. Physical Therapy 66(1):32-5, 1986.

Palmieri GMA, Bertorini TE, Bhattacharya SK, Nutting DF, Hinton AB. Muscle calcium

accumulation in muscular dystrophy. - In - Intracellular Calcium Regulation, Baker H, Gietzen K,

Rosenthal J, Rudel R, Wolf HU (eds.), Manchester University Press, Manchester, UK, 1985.

Koch B, Bertorini TE, Eng G, Boehm R. Severe multicore disease associated with reaction to

anesthesia. Arch Neurol 42:1204-6, 1985.

Bertorini TE, Igarashi M. Postpoliomyelitis muscle pseudohypertrophy. Muscle & Nerve 8:644-9,

1985.

Bertorini TE, Palmieri GMA, Griffin J, Chesney C, Pifer D, Verling L, Airozo D, Fox IH. Chronic

allopurinol and adenine therapy in DMD: effects on muscle function nucleotide degradation and

muscle ATP and ADP content. Neurology 35:61-5, 1985.

Fox IH, Shefner R, Palmieri GMA, Bertorini TE. Duchenne muscular dystrophy: normal ATP

turnover in cultured cells. Neurology 35:1521-4, 1985.

Bertorini TE. Requirements for adequate clinical trials in Duchenne muscular dystrophy. Muscle

& Nerve 8:470-3, 1985.

Bertorini TE, Shively V, Taylor B, Palmieri GMA, Fox IH. ATP degradation products after

ischemic exercise: hereditary lack of phosphorylase of carnitine palmityltransferase. Neurology

35:1355-7, 1985.

Mendell JR, Kissel JT, Kennedy MS, Sahenk Z, Grinvalsky HT, Pittman GL, Kyler RS, Roelofs RI,

Whitaker JN, Bertorini, T. Plasma exchange and prednisone in Guillain-Barré syndrome: A

controlled randomized trial. Neurology 35:1551-5, 1985.

Mendell JR, Kissel JT, Kennedy MS, Sahenk Z, Grinvalsky HT, Pittman GL, Kyler RS, Roelofs RI,

Whitaker JN, Bertorini, TE. Plasma exchange and prednisone in acute inflammatory

polyradiculoneuropathy: a controlled randomized trial. J Clin Apheresis 2:332-342, 1985.

Reimao R, Lemmi H, Bertorini TE. Sonolencia excessiva diurna, apneia do sono tipo central e

distrofie miotonica. Arq. Neuro-Psiquiatria (Sao Paulo) 43(4):391-5, 1985.

Bertorini TE. Clinical trials in Duchenne muscular dystrophy: the experience in Memphis,

Tennessee. Italian Journal of Neurological Sciences, Suppl. 1:153-8, 1984.

Bertorini TE, Bhattacharya SK, Palmieri GMA. Studies of calcium content in muscular dystrophy.

Italian Journal of Neurological Sciences Suppl. 1:103-10, 1984.

06/08/2017 30

Bertorini TE, Cornelio F, Bhattacharya SK, Palmieri GMA, Dones I, Dworzak F, Brambati B.

Calcium and magnesium content in fetuses at risk and pre-necrotic Duchenne muscular dystrophy.

Neurology 34:1436-40, 1984.

Geoffrey VC, Bernthal JE, Bertorini TE, Bosma JF. Interaction of experimentally elicited auricular

cough with voluntary phonation. Folia Phoniatr 36:31-9, 1984.

Niakan E, Bertorini TE, Lemmi H, Medeiros M, Drewry R, Kish E. Spinocerebellar degeneration

and slow saccades in 3 generations of a kinship: clinical and electrophysiologic findings. Arq

Neuropsiquiatr (Brazil) 42(3):232-41, 1984.

Whitaker J, Bertorini T, Mendell J. Immunocytochemical studies of cathepsin D in human skeletal

muscle. Ann Neurol 13:133-42, 1983.

Bhattacharya SK, Palmieri GMA, Bertorini TE, Nutting DF. The effects of Diltiazem in dystrophic

hamsters. Muscle & Nerve 5:73-8, 1982.

Bertorini T, Palmieri G, Bhattacharya S. Beneficial effects of dantrolene sodium in exercise-

induced muscle pains calcium mediated? Lancet. 1982 March 13; 1 (8272):616-7.

Lewis JA, Bertorini TE. Duchenne muscular dystrophy and Tourette syndrome. Neurology. 1982

Mar; 32(3)329.

Gottdiener JS, Hawley RJ, Maron BJ, Bertorini TE, Engel WK. Characteristics of the cardiac

hypertrophy in Friedreich's Ataxia. American Heart Journal, St. Louis 103(4):525-31, 1982.

Engel AG, Lambert EH, Mulder DM, Torres CF, Sahashi K, Bertorini TE, Whitaker JN. A newly

recognized congenital myasthenic syndrome attributed to a prolonged open time of the

acetylcholine-induced ion channel. Ann Neurol 11:553-69, 1982.

Bertorini TE, Bhattacharya SK, Palmieri GMA, Chesney CM, Pifer D, Baker B. Muscle calcium

and magnesium content in Duchenne muscular dystrophy. Neurology 32:1088-92, 1982.

Niakan E, Bertorini TE, Acchiardo SR, Werner MF. Procainamide induced myasthenia-like

weakness in a patient with peripheral neuropathy. Arch Neurol 38:378-9, 1981.

Whitaker JN, Bertorini TE, Mendell JR. Immunocytochemical studies of cathepsin D in human

skeletal muscle. Trans Am Neurol Assoc. 1981; 106:219-21.

Bertorini TE, Palmieri GMA, Airozo D, Edwards L, Fox IH. Increased adenine nucleotide turnover

in Duchenne muscular dystrophy. Pediatric Research 15:1478-82, 1981.

Palmieri GMA, Nutting DF, Bhattacharya SK, Bertorini TE, Williams JC. Parathyroid ablation in

dystrophic hamsters: effects on Ca content and histology of heart, diaphragm, and rectus femoris.

Journal for Clinical Investigations 68:646-54, 1981.

Niakan E, Pitner S, Whitaker J, Bertorini TE. The use of immuno¬suppressive agents in

corticosteroid-refractory childhood dermatomyositis. Neurology 30:286-91, 1980.

Bertorini TE, Yeh Y, Trevison C, Stadlan E, Sabesin S, DiMauro S. Carnitine palmityl transferase

deficiency: myoglobinuria and respiratory failure. Neurology 30:263-71, 1980.

Engel AG, Lambert EH, Mulder DM, Torres CF, Sahashi K, Bertorini TE, Whitaker JN.

Investigations of 3 cases of a newly recognized familial, congenital myasthenic syndrome.

Transactions American Neurological Assoc. 104:1-5, 1980.

Bertorini TE. Neuromuscular Diseases - In - Synopsis of Pediatrics, 5th Edition, James Hughes,

(ed.), The Mosby Company, 1979.

Brumback R, Bertorini TE, Engel WK, Trotter SL, Oliver KL, Zirzow SC. The effect of

acetylcholine receptor blockade on fibrillation and myotonia in rat skeletal muscle. Archives of

Neurology 35:8-10, 1978.

Brumback RA, Bertorini TE, Engel WK, Trotter JL, Oliver KL, Zirzow GC. The effect of

pharmacologic acetylcholine receptor on fibrillation and myotonia in rat skeletal muscle. Arch

Neurol. 1978 Jan;35(1):8-10.

Bertorini TE, Engel WK, DiChiro G, Dalakas M. Leukoencephalopathy in oculocraniosomatic

neuromuscular disease with ragged-red fibers: (mitochondrial abnormalities) demonstration by

computerized tomography. Archives of Neurology 35:643-7, 1978.

06/08/2017 31

Brumback RA, Bertorini TE, Lieberman J. Inside-of-the-body test drawings performed by patients

with neuromuscular diseases: a preliminary report. Perceptual and Motor Skills 47:155-60, 1978.


observations in 6 patients with muscle phosphorylase deficiency. Trans Am Neurol Assoc 103:141,

1977.


observations in 6 patients with muscle phosphorylase deficiency. Trans Am Neurol Assoc 103: 141,

1977.

Bertorini TE, Jacome D. Diabetic neuropathies, Rev. Soc. Col. Endoc., pages 34-42, 12/76.

Jacome D, Bertorini TE. Myasthenia Gravis, Revision, Universitas Medica XVIII, pages 1-10,

1976. Jacome D, Bertorini TE. Hepatic encephalopathy. Universitas Medica XVII, 1974, Bogota,

Columbia.

Bertorini TE. Nerve conduction velocity in normal Peruvians. Medical Thesis, San Marcos

University, Lima, Peru, 1970.

POSTERS

Mays, W., Talbot, L., Metter, J., Pan Izaguirre, M., Brede, E., Maturana, M., Bertorini, T.,

Alexandrov, A., accepted abstract, Neuromuscular Electrostimulation (NMES) used for increasing

quadriceps strength may also provide mild analgesia; poster presentation AAN, Baltimore, MD,

April 2017.

Mays, W., Bertorini, T.E., Talbot, L., Metter, J., Poster presentation, Focal Bioimpedance (BIA) and

Its Superiority Over Total Body BIA; accepted at the American Neurological Association’s (ANA)

2016 Annual Meeting. Baltimore, MD, October 16-18, 2016.

Mays, W., Bertorini, T., Talbot, L., Metter, J., Bello, R., Nash, N., Yambem, O., Maturana, M., Pan

Izaguirre, M., Poster presentation Biompedance in Amyotrophic Lateral Sclerosis and Other

Neuromuscular Diseases: Potential Pitfalls of the Total Body Technique; NorthEast ALS Consortium

(NEALS) 2016 Annual Meeting. Clearwater, FL, October 4-6, 2016.

Yambem, O., Shadle, M., Bello, R., Shen, L., Bertorini, T., A Case Series of Inclusion Body

Myositis; ANA Poster Presentation, Baltimore, 2016.

Poster Discussion Session: Muscular Dystrophy. An Evaluation of Social and Medical Support for

Adult Stage Duchenne Muscular Dystrophy. Helen Ly, Tulio Bertorini. American Academy of

Neurology. San Diego, March 2013.

A Multicenter Screening Trial of the Safety and Efficacy of Rasagiline in People with ALS. Yunxia

Wang, Dan Moore, Jonathan Katz, David Saperstein, David Walk, Ericka Simpson, Angela Genge,

Tulio Bertorini, Jose Fernandez, Andrea Swenson, Russell Swerdlow, Mazen Dimachkie, April

McVay, Laura Herbelin, Zachary Macci, Richard Barohn, WALS Rasagline. American Academy of

Neurology, Chicago, 2013.

A Multicenter Screening Trial of the Safety and Efficacy of Rasagiline in People with ALS. Yunxia

Wang, Dan Moore, Jonathan Katz, David Saperstein, David Walk, Ericka Simpson, Angela Genge,

Tulio Bertorini, Jose Fernandez, Andrea Swenson, Russell Swerdlow, Mazen Dimachkie, April

McVay, Laura Herbelin, Zachary Macci, Richard Barohn, WALS Rasagline. American Academy of

Neurology, San Diego, March 20, 2013.

06/08/2017 32

CLINICAL RESEARCH EXPERIENCE

1. Open-Label Multi-Center Trial of Riluzole 50 mg BID in Treatment of Amyotrophic Lateral Sclerosis (ALS). Principal Investigator. August 1995 - March 1996.

2. A Phase III, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Recombinant Human Nerve Growth Factor (rhNGF) in Subjects with Diabetic Neuropathy. Principal Investigator. May 1997 - April 1999.

3. A Randomized Multi-Center, Double-Blind, Placebo-Controlled Trial on Static Magnetic Field Therapy for Symptomatic Diabetic Neuropathy. Sub-Investigator. 2002 - 2003.

4. A Randomized Study of Daily vs. high Dose Weekly Prednisone Therapy in Duchenne Muscular Dystrophy, 2005 - 2007.

5. CINRG Randomized Controlled Trial of Creatine and Glutamine in Duchenne Muscular Dystrophy.

6. Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies.

7. A Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets for Treatment of Stable Walking Deficits in Post-Ischemic Stroke.

8. An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits in Subjects Who Participated in the DALF-PS-1016 Study (MILESTONE).

9. A Multi-Center Screening Trial of Safety and Efficacy of Rasagiline in Subjects with Amyotrophic Lateral Sclerosis (ALS). University of Kansas.

10. An Open-Label, Multi-Center, 48-Week Study with a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy. Sarepta.

11. An Open Label, Expanded Access Protocol Intended to Provide Treatment with MP-104

(Deflazacort) to U.S. Children, Adolescents, and/or Adults with Duchenne Muscular Dystrophy-

Marathon Pharmaceuticals.

12. Longitudinal Study of the Relationship between Impairment, Activity Limitation, Participation and Quality of Life in Persons with Confirmed Duchenne Muscular Dystrophy (DMD), 2007 – Present.

13. A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects with Amyotrophic Lateral Sclerosis. Phase 2b. Protocol #: MNK14042068. Mallinckrodt. 2016 – Present.

14. Entitled Longitudinal Cohort Study of Resource use and Cost of Mild Cognitive lmpairment and Mild Dementia due to Alzheimer's Disease in the United States (GERAS-US). Protocol #:118A-US-B004. Eli Lilly. June 2017 - Present.

PROFESSIONAL EXPERIENCE - Interspondinterspond.com/wp-content/uploads/2016/12/... · Macchi Z1,...

Documents

Transcript of PROFESSIONAL EXPERIENCE - Interspondinterspond.com/wp-content/uploads/2016/12/... · Macchi Z1,...